Financial Metrics
ISRG INTUITIVE SURGICAL INCFinancial Statements
Grouped by statementIncome Statement
Metrics: 6Revenue
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 594500000.0 | — | USD | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 670100000.0 | +12.7% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 682900000.0 | +1.9% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 679600000.0 | -0.5% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 758800000.0 | +11.7% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 807800000.0 | +6.5% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 847500000.0 | +4.9% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 909300000.0 | +7.3% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 920900000.0 | +1.3% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 973700000.0 | +5.7% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 1098900000.0 | +12.9% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 1128200000.0 | +2.7% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 1099500000.0 | -2.5% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 852100000.0 | -22.5% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 1077700000.0 | +26.5% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 1292100000.0 | +19.9% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 1464000000.0 | +13.3% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 1403300000.0 | -4.1% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 1487700000.0 | +6.0% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 1522100000.0 | +2.3% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 1557400000.0 | +2.3% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 1696200000.0 | +8.9% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 1755900000.0 | +3.5% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 1743700000.0 | -0.7% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 1890600000.0 | +8.4% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 2009900000.0 | +6.3% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 2038100000.0 | +1.4% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 2253400000.0 | +10.6% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 2440000000.0 | +8.3% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 2505100000.0 | +2.7% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 2706500000.0 | — | USD | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 3138200000.0 | +16.0% | USD | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 3724200000.0 | +18.7% | USD | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 4478500000.0 | +20.3% | USD | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 4358400000.0 | -2.7% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 5710100000.0 | +31.0% | USD | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 6222200000.0 | +9.0% | USD | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 7124100000.0 | +14.5% | USD | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 8352100000.0 | +17.2% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 10064700000.0 | +20.5% | USD | 10-K | 2026-02-03 |
Gross Profit
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 405000000.0 | — | USD | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 470900000.0 | +16.3% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 487000000.0 | +3.4% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 469800000.0 | -3.5% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 530100000.0 | +12.8% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 568100000.0 | +7.2% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 593800000.0 | +4.5% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 632300000.0 | +6.5% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 642300000.0 | +1.6% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 669600000.0 | +4.3% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 759000000.0 | +13.4% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 785600000.0 | +3.5% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 738200000.0 | -6.0% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 502900000.0 | -31.9% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 724300000.0 | +44.0% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 902600000.0 | +24.6% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 1023700000.0 | +13.4% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 971400000.0 | -5.1% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 1009700000.0 | +3.9% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 1023300000.0 | +1.3% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 1052100000.0 | +2.8% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 1113000000.0 | +5.8% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 1171900000.0 | +5.3% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 1167200000.0 | -0.4% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 1245400000.0 | +6.7% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 1372700000.0 | +10.2% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 1373900000.0 | +0.1% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 1457700000.0 | +6.1% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 1617900000.0 | +11.0% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 1662400000.0 | +2.8% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 1892900000.0 | — | USD | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 2202000000.0 | +16.3% | USD | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 2604100000.0 | +18.3% | USD | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 3110200000.0 | +19.4% | USD | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 2861200000.0 | -8.0% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 3958500000.0 | +38.4% | USD | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 4196000000.0 | +6.0% | USD | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 4729500000.0 | +12.7% | USD | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 5634200000.0 | +19.1% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 6642300000.0 | +17.9% | USD | 10-K | 2026-02-03 |
Operating Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 179000000.0 | — | USD | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 245400000.0 | +37.1% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 256400000.0 | +4.5% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 193400000.0 | -24.6% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 259900000.0 | +34.4% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 280600000.0 | +8.0% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 276700000.0 | -1.4% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 277400000.0 | +0.3% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 313300000.0 | +12.9% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 252200000.0 | -19.5% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 359000000.0 | +42.3% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 365700000.0 | +1.9% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 283000000.0 | -22.6% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 80600000.0 | -71.5% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 270400000.0 | +235.5% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 416800000.0 | +54.1% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 511200000.0 | +22.6% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 442600000.0 | -13.4% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 408100000.0 | -7.8% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 397600000.0 | -2.6% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 398900000.0 | +0.3% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 387600000.0 | -2.8% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 463200000.0 | +19.5% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 465800000.0 | +0.6% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 469400000.0 | +0.8% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 567300000.0 | +20.9% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 577300000.0 | +1.8% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 578100000.0 | +0.1% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 743400000.0 | +28.6% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 759700000.0 | +2.2% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 949700000.0 | — | USD | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 1062900000.0 | +11.9% | USD | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 1199400000.0 | +12.8% | USD | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 1374500000.0 | +14.6% | USD | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 1049800000.0 | -23.6% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 1821000000.0 | +73.5% | USD | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 1577100000.0 | -13.4% | USD | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 1766800000.0 | +12.0% | USD | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 2348900000.0 | +32.9% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 2945500000.0 | +25.4% | USD | 10-K | 2026-02-03 |
Net Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 136400000.0 | — | USD | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 184500000.0 | +35.3% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 211000000.0 | +14.4% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 180800000.0 | -14.3% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 223000000.0 | +23.3% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 298600000.0 | +33.9% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 287300000.0 | -3.8% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 254600000.0 | -11.4% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 291800000.0 | +14.6% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 304000000.0 | +4.2% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 316400000.0 | +4.1% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 398700000.0 | +26.0% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 316200000.0 | -20.7% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 70200000.0 | -77.8% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 316800000.0 | +351.3% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 435200000.0 | +37.4% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 523000000.0 | +20.2% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 387200000.0 | -26.0% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 369400000.0 | -4.6% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 313600000.0 | -15.1% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 324700000.0 | +3.5% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 360800000.0 | +11.1% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 426000000.0 | +18.1% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 419800000.0 | -1.5% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 547400000.0 | +30.4% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 531500000.0 | -2.9% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 570600000.0 | +7.4% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 703700000.0 | +23.3% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 664200000.0 | -5.6% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 709200000.0 | +6.8% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 738300000.0 | — | USD | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 670900000.0 | -9.1% | USD | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 1125000000.0 | +67.7% | USD | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 1381800000.0 | +22.8% | USD | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 1066800000.0 | -22.8% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 1728100000.0 | +62.0% | USD | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 1344400000.0 | -22.2% | USD | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 1817300000.0 | +35.2% | USD | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 2337500000.0 | +28.6% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 2876600000.0 | +23.1% | USD | 10-K | 2026-02-03 |
EPS Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 3.62 | — | USD/shares | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 4.82 | +33.1% | USD/shares | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 1.82 | -62.2% | USD/shares | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 1.62 | -11.0% | USD/shares | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 2.01 | +24.1% | USD/shares | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 2.67 | +32.8% | USD/shares | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 2.55 | -4.5% | USD/shares | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 2.25 | -11.8% | USD/shares | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 2.57 | +14.2% | USD/shares | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 2.67 | +3.9% | USD/shares | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 2.76 | +3.4% | USD/shares | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 3.44 | +24.6% | USD/shares | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 2.69 | -21.8% | USD/shares | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 0.58 | -78.4% | USD/shares | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 0.89 | +53.4% | USD/shares | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 1.2 | +34.8% | USD/shares | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 1.45 | +20.8% | USD/shares | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 1.07 | -26.2% | USD/shares | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 1.02 | -4.7% | USD/shares | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 0.86 | -15.7% | USD/shares | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 0.91 | +5.8% | USD/shares | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 1.01 | +11.0% | USD/shares | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 1.2 | +18.8% | USD/shares | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 1.18 | -1.7% | USD/shares | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 1.54 | +30.5% | USD/shares | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 1.48 | -3.9% | USD/shares | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 1.59 | +7.4% | USD/shares | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 1.95 | +22.6% | USD/shares | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 1.84 | -5.6% | USD/shares | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 1.98 | +7.6% | USD/shares | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 6.43 | — | USD/shares | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 6.01 | -6.5% | USD/shares | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 9.92 | +65.1% | USD/shares | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 3.98 | -59.9% | USD/shares | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 3.02 | -24.1% | USD/shares | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 4.79 | +58.6% | USD/shares | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 3.72 | -22.3% | USD/shares | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 5.12 | +37.6% | USD/shares | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 6.54 | +27.7% | USD/shares | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 8.0 | +22.3% | USD/shares | 10-K | 2026-02-03 |
EPS Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 3.54 | — | USD/shares | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 4.71 | +33.1% | USD/shares | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 1.77 | -62.4% | USD/shares | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 1.57 | -11.3% | USD/shares | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 1.94 | +23.6% | USD/shares | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 2.56 | +32.0% | USD/shares | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 2.44 | -4.7% | USD/shares | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 2.15 | -11.9% | USD/shares | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 2.45 | +14.0% | USD/shares | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 2.56 | +4.5% | USD/shares | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 2.67 | +4.3% | USD/shares | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 3.33 | +24.7% | USD/shares | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 2.62 | -21.3% | USD/shares | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 0.57 | -78.2% | USD/shares | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 0.87 | +52.6% | USD/shares | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 1.17 | +34.5% | USD/shares | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 1.42 | +21.4% | USD/shares | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 1.04 | -26.8% | USD/shares | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 1.0 | -3.8% | USD/shares | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 0.85 | -15.0% | USD/shares | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 0.9 | +5.9% | USD/shares | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 1.0 | +11.1% | USD/shares | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 1.18 | +18.0% | USD/shares | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 1.16 | -1.7% | USD/shares | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 1.51 | +30.2% | USD/shares | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 1.46 | -3.3% | USD/shares | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 1.56 | +6.8% | USD/shares | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 1.92 | +23.1% | USD/shares | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 1.81 | -5.7% | USD/shares | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 1.95 | +7.7% | USD/shares | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 6.26 | — | USD/shares | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 5.77 | -7.8% | USD/shares | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 9.49 | +64.5% | USD/shares | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 3.85 | -59.4% | USD/shares | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 2.94 | -23.6% | USD/shares | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 4.66 | +58.5% | USD/shares | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 3.65 | -21.7% | USD/shares | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 5.03 | +37.8% | USD/shares | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 6.42 | +27.6% | USD/shares | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 7.87 | +22.6% | USD/shares | 10-K | 2026-02-03 |
Balance Sheet
Metrics: 9Cash and Equivalents
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 980500000.0 | — | USD | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 1193500000.0 | +21.7% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 1021600000.0 | -14.4% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2016-12-31 | 1036600000.0 | +1.5% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 708600000.0 | -31.6% | USD | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 696500000.0 | -1.7% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 875000000.0 | +25.6% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 648200000.0 | -25.9% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 974700000.0 | +50.4% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 1203500000.0 | +23.5% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 1008300000.0 | -16.2% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 857900000.0 | -14.9% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 875700000.0 | +2.1% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 790300000.0 | -9.8% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 969600000.0 | +22.7% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 1167600000.0 | +20.4% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 1223800000.0 | +4.8% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 2035600000.0 | +66.3% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 1370600000.0 | -32.7% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 1622600000.0 | +18.4% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 1401800000.0 | -13.6% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 1615500000.0 | +15.2% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 1346700000.0 | -16.6% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 1290900000.0 | -4.1% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 1103100000.0 | -14.5% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 1536100000.0 | +39.3% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 1538000000.0 | +0.1% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 1581200000.0 | +2.8% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 2143000000.0 | +35.5% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 3435400000.0 | +60.3% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 3602000000.0 | +4.8% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 2750100000.0 | -23.7% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 2839500000.0 | +3.3% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 3036700000.0 | +6.9% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 2413300000.0 | -20.5% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 2027400000.0 | -16.0% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 2573800000.0 | +27.0% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 3403100000.0 | +32.2% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 2806600000.0 | -17.5% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 1036600000.0 | — | USD | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 648200000.0 | -37.5% | USD | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 857900000.0 | +32.4% | USD | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 1167600000.0 | +36.1% | USD | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 1622600000.0 | +39.0% | USD | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 1290900000.0 | -20.4% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 1581200000.0 | +22.5% | USD | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 2750100000.0 | +73.9% | USD | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 2027400000.0 | -26.3% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 3368000000.0 | +66.1% | USD | 10-K | 2026-02-03 |
Accounts Receivable
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 325900000.0 | — | USD | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 403800000.0 | +23.9% | USD | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 432000000.0 | +7.0% | USD | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 430200000.0 | -0.4% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 412900000.0 | -4.0% | USD | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 481100000.0 | +16.5% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 468000000.0 | -2.7% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 507900000.0 | +8.5% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 474900000.0 | -6.5% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 532500000.0 | +12.1% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 580400000.0 | +9.0% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 682300000.0 | +17.6% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 547600000.0 | -19.7% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 633400000.0 | +15.7% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 639000000.0 | +0.9% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 645200000.0 | +1.0% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 527600000.0 | -18.2% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 508800000.0 | -3.6% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 588600000.0 | +15.7% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 645500000.0 | +9.7% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 654300000.0 | +1.4% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 699900000.0 | +7.0% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 695000000.0 | -0.7% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 782700000.0 | +12.6% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 906100000.0 | +15.8% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 838500000.0 | -7.5% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 849600000.0 | +1.3% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 942100000.0 | +10.9% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 925300000.0 | -1.8% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 904200000.0 | -2.3% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 962700000.0 | +6.5% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 1130200000.0 | +17.4% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 1127900000.0 | -0.2% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 1109100000.0 | -1.7% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 1153000000.0 | +4.0% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 1225400000.0 | +6.3% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 1221500000.0 | -0.3% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 1269200000.0 | +3.9% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 1259700000.0 | -0.7% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 430200000.0 | — | USD | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 507900000.0 | +18.1% | USD | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 682300000.0 | +34.3% | USD | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 645200000.0 | -5.4% | USD | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 645500000.0 | +0.0% | USD | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 782700000.0 | +21.3% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 942100000.0 | +20.4% | USD | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 1130200000.0 | +20.0% | USD | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 1225400000.0 | +8.4% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 1527300000.0 | +24.6% | USD | 10-K | 2026-02-03 |
Inventory
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 163000000.0 | — | USD | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 169200000.0 | +3.8% | USD | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 183500000.0 | +8.5% | USD | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 182300000.0 | -0.7% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 213500000.0 | +17.1% | USD | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 214200000.0 | +0.3% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 225200000.0 | +5.1% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 241200000.0 | +7.1% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 283600000.0 | +17.6% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 331500000.0 | +16.9% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 370100000.0 | +11.6% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 409000000.0 | +10.5% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 468300000.0 | +14.5% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 512800000.0 | +9.5% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 579600000.0 | +13.0% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 595500000.0 | +2.7% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 620300000.0 | +4.2% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 645500000.0 | +4.1% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 662900000.0 | +2.7% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 601500000.0 | -9.3% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 576800000.0 | -4.1% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 569700000.0 | -1.2% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 584900000.0 | +2.7% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 587100000.0 | +0.4% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 653000000.0 | +11.2% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 724000000.0 | +10.9% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 837100000.0 | +15.6% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 893200000.0 | +6.7% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 946600000.0 | +6.0% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 1005200000.0 | +6.2% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 1147500000.0 | +14.2% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 1220600000.0 | +6.4% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 1299300000.0 | +6.4% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 1383900000.0 | +6.5% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 1481700000.0 | +7.1% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 1487200000.0 | +0.4% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 1553600000.0 | +4.5% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 1667000000.0 | +7.3% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 1781900000.0 | +6.9% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 182300000.0 | — | USD | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 241200000.0 | +32.3% | USD | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 409000000.0 | +69.6% | USD | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 595500000.0 | +45.6% | USD | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 601500000.0 | +1.0% | USD | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 587100000.0 | -2.4% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 893200000.0 | +52.1% | USD | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 1220600000.0 | +36.7% | USD | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 1487200000.0 | +21.8% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 1840000000.0 | +23.7% | USD | 10-K | 2026-02-03 |
Current Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 2406400000.0 | — | USD | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 2827400000.0 | +17.5% | USD | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 2911400000.0 | +3.0% | USD | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 3250400000.0 | +11.6% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 2167700000.0 | -33.3% | USD | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 2642200000.0 | +21.9% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 2928900000.0 | +10.9% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 2808900000.0 | -4.1% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 3381700000.0 | +20.4% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 3986100000.0 | +17.9% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 4252600000.0 | +6.7% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 4333200000.0 | +1.9% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 4025000000.0 | -7.1% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 4071600000.0 | +1.2% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 4317000000.0 | +6.0% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 4662600000.0 | +8.0% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 4691500000.0 | +0.6% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 5899000000.0 | +25.7% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 6300300000.0 | +6.8% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 6625900000.0 | +5.2% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 6066400000.0 | -8.4% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 6016600000.0 | -0.8% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 5728000000.0 | -4.8% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 5844900000.0 | +2.0% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 5803200000.0 | -0.7% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 6292500000.0 | +8.4% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 6293100000.0 | +0.0% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 6253000000.0 | -0.6% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 6877000000.0 | +10.0% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 8031800000.0 | +16.8% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 8902900000.0 | +10.8% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 7888000000.0 | -11.4% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 7632700000.0 | -3.2% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 7654300000.0 | +0.3% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 7215600000.0 | -5.7% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 7111000000.0 | -1.4% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 7657800000.0 | +7.7% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 8745900000.0 | +14.2% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 8525300000.0 | -2.5% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 3250400000.0 | — | USD | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 2808900000.0 | -13.6% | USD | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 4333200000.0 | +54.3% | USD | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 4662600000.0 | +7.6% | USD | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 6625900000.0 | +42.1% | USD | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 5844900000.0 | -11.8% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 6253000000.0 | +7.0% | USD | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 7888000000.0 | +26.1% | USD | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 7111000000.0 | -9.9% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 9779500000.0 | +37.5% | USD | 10-K | 2026-02-03 |
Total Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 5306300000.0 | — | USD | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 5780800000.0 | +8.9% | USD | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 6174700000.0 | +6.8% | USD | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 6486900000.0 | +5.1% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 4808000000.0 | -25.9% | USD | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 5250800000.0 | +9.2% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 5644600000.0 | +7.5% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 5776800000.0 | +2.3% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 6426200000.0 | +11.2% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 6849600000.0 | +6.6% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 7318600000.0 | +6.8% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 7846700000.0 | +7.2% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 8234900000.0 | +4.9% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 8531600000.0 | +3.6% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 9131300000.0 | +7.0% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 9733200000.0 | +6.6% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 9891100000.0 | +1.6% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 10103600000.0 | +2.1% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 10617500000.0 | +5.1% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 11168900000.0 | +5.2% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 11540400000.0 | +3.3% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 12297000000.0 | +6.6% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 12934600000.0 | +5.2% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 13555000000.0 | +4.8% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 13678400000.0 | +0.9% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 13705200000.0 | +0.2% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 13260800000.0 | -3.2% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 12974000000.0 | -2.2% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 13053200000.0 | +0.6% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 13903300000.0 | +6.5% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 14712700000.0 | +5.8% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 15441500000.0 | +5.0% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 15828000000.0 | +2.5% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 16649900000.0 | +5.2% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 17743400000.0 | +6.6% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 18743200000.0 | +5.6% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 19220400000.0 | +2.5% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 20163200000.0 | +4.9% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 19351800000.0 | -4.0% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 6486900000.0 | — | USD | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 5776800000.0 | -10.9% | USD | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 7846700000.0 | +35.8% | USD | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 9733200000.0 | +24.0% | USD | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 11168900000.0 | +14.8% | USD | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 13555000000.0 | +21.4% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 12974000000.0 | -4.3% | USD | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 15441500000.0 | +19.0% | USD | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 18743200000.0 | +21.4% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 20458700000.0 | +9.2% | USD | 10-K | 2026-02-03 |
Current Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 452900000.0 | — | USD | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 489500000.0 | +8.1% | USD | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 528100000.0 | +7.9% | USD | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 596500000.0 | +13.0% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 558200000.0 | -6.4% | USD | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 599800000.0 | +7.5% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 615700000.0 | +2.7% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 662800000.0 | +7.6% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 581200000.0 | -12.3% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 666400000.0 | +14.7% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 703300000.0 | +5.5% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 820600000.0 | +16.7% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 740200000.0 | -9.8% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 807500000.0 | +9.1% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 930900000.0 | +15.3% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 1030200000.0 | +10.7% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 945900000.0 | -8.2% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 924800000.0 | -2.2% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 894700000.0 | -3.3% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 965200000.0 | +7.9% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 904600000.0 | -6.3% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 1004600000.0 | +11.1% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 1027300000.0 | +2.3% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 1149800000.0 | +11.9% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 1112200000.0 | -3.3% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 1175000000.0 | +5.6% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 1233400000.0 | +5.0% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 1422100000.0 | +15.3% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 1307400000.0 | -8.1% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 1538400000.0 | +17.7% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 1676400000.0 | +9.0% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 1658700000.0 | -1.1% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 1375100000.0 | -17.1% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 1487500000.0 | +8.2% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 1676800000.0 | +12.7% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 1745300000.0 | +4.1% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 1538100000.0 | -11.9% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 1692600000.0 | +10.0% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 1803200000.0 | +6.5% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 596500000.0 | — | USD | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 662800000.0 | +11.1% | USD | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 820600000.0 | +23.8% | USD | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 1030200000.0 | +25.5% | USD | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 965200000.0 | -6.3% | USD | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 1149800000.0 | +19.1% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 1422100000.0 | +23.7% | USD | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 1658700000.0 | +16.6% | USD | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 1745300000.0 | +5.2% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 2006200000.0 | +14.9% | USD | 10-K | 2026-02-03 |
Total Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 555900000.0 | — | USD | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 599300000.0 | +7.8% | USD | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 632900000.0 | +5.6% | USD | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 709100000.0 | +12.0% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 680500000.0 | -4.0% | USD | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 728500000.0 | +7.1% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 684700000.0 | -6.0% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 996400000.0 | +45.5% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 919800000.0 | -7.7% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 980400000.0 | +6.6% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 1030100000.0 | +5.1% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 1159200000.0 | +12.5% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 1194500000.0 | +3.0% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 1252000000.0 | +4.8% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 1354200000.0 | +8.2% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 1448500000.0 | +7.0% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 1360600000.0 | -6.1% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 1337200000.0 | -1.7% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 1330800000.0 | -0.5% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 1409800000.0 | +5.9% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 1350200000.0 | -4.2% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 1417500000.0 | +5.0% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 1475100000.0 | +4.1% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 1603500000.0 | +8.7% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 1521500000.0 | -5.1% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 1622800000.0 | +6.7% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 1686800000.0 | +3.9% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 1861400000.0 | +10.4% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 1759000000.0 | -5.5% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 1943600000.0 | +10.5% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 2089200000.0 | +7.5% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 2044200000.0 | -2.2% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 1781600000.0 | -12.8% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 1853400000.0 | +4.0% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 2065900000.0 | +11.5% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 2213600000.0 | +7.1% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 2012700000.0 | -9.1% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 2210100000.0 | +9.8% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 2309700000.0 | +4.5% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 709100000.0 | — | USD | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 996400000.0 | +40.5% | USD | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 1159200000.0 | +16.3% | USD | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 1448500000.0 | +25.0% | USD | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 1409800000.0 | -2.7% | USD | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 1603500000.0 | +13.7% | USD | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 1861400000.0 | +16.1% | USD | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 2044200000.0 | +9.8% | USD | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 2213600000.0 | +8.3% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 2517000000.0 | +13.7% | USD | 10-K | 2026-02-03 |
Stockholders' Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 4750400000.0 | — | USD | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 5181500000.0 | +9.1% | USD | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 5541800000.0 | +7.0% | USD | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 5777800000.0 | +4.3% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 4127500000.0 | -28.6% | USD | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 4522300000.0 | +9.6% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 4959900000.0 | +9.7% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 4780400000.0 | -3.6% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2018-03-31 | 5506400000.0 | +15.2% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2018-06-30 | 5869200000.0 | +6.6% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2018-09-30 | 6288500000.0 | +7.1% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2018-12-31 | 6687500000.0 | +6.3% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2019-03-31 | 7040400000.0 | +5.3% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2019-06-30 | 7279600000.0 | +3.4% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2019-09-30 | 7777100000.0 | +6.8% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2019-12-31 | 8284700000.0 | +6.5% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2020-03-31 | 8530500000.0 | +3.0% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2020-06-30 | 8766400000.0 | +2.8% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2020-09-30 | 9286700000.0 | +5.9% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2020-12-31 | 9759100000.0 | +5.1% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2021-03-31 | 10190200000.0 | +4.4% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2021-06-30 | 10879500000.0 | +6.8% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2021-09-30 | 11459500000.0 | +5.3% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2021-12-31 | 11951500000.0 | +4.3% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2022-03-31 | 12156900000.0 | +1.7% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2022-06-30 | 12082400000.0 | -0.6% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2022-09-30 | 11574000000.0 | -4.2% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2022-12-31 | 11112600000.0 | -4.0% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2023-03-31 | 11294200000.0 | +1.6% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2023-06-30 | 11959700000.0 | +5.9% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2023-09-30 | 12623500000.0 | +5.6% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2023-12-31 | 13397300000.0 | +6.1% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2024-03-31 | 14046400000.0 | +4.8% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2024-06-30 | 14796500000.0 | +5.3% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2024-09-30 | 15677500000.0 | +6.0% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2024-12-31 | 16529600000.0 | +5.4% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 17207700000.0 | +4.1% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-06-30 | 17953100000.0 | +4.3% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-09-30 | 17042100000.0 | -5.1% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 5820500000.0 | — | USD | 10-K | 2020-02-07 |
| Annual | 2017-12-31 | 4780400000.0 | -17.9% | USD | 10-K | 2021-02-10 |
| Annual | 2018-12-31 | 6687500000.0 | +39.9% | USD | 10-K | 2022-02-03 |
| Annual | 2019-12-31 | 8284700000.0 | +23.9% | USD | 10-K | 2023-02-10 |
| Annual | 2020-12-31 | 9759100000.0 | +17.8% | USD | 10-K | 2024-01-31 |
| Annual | 2021-12-31 | 11951500000.0 | +22.5% | USD | 10-K | 2025-01-31 |
| Annual | 2022-12-31 | 11112600000.0 | -7.0% | USD | 10-K | 2026-02-03 |
| Annual | 2023-12-31 | 13397300000.0 | +20.6% | USD | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 16529600000.0 | +23.4% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 17941700000.0 | +8.5% | USD | 10-K | 2026-02-03 |
Long-Term Debt
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Cash Flow
Metrics: 4Operating Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 226800000.0 | — | USD | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 488500000.0 | +115.4% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 757300000.0 | +55.0% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 241500000.0 | -68.1% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 458000000.0 | +89.6% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 811900000.0 | +77.3% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 280200000.0 | -65.5% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 511700000.0 | +82.6% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 831500000.0 | +62.5% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 333200000.0 | -59.9% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 649200000.0 | +94.8% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 1045500000.0 | +61.0% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 352800000.0 | -66.3% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 582700000.0 | +65.2% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 857300000.0 | +47.1% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 477600000.0 | -44.3% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 1020300000.0 | +113.6% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 1521700000.0 | +49.1% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 223000000.0 | -85.3% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 669700000.0 | +200.3% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 1052900000.0 | +57.2% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 371400000.0 | -64.7% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 1037100000.0 | +179.2% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 1585500000.0 | +52.9% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 265400000.0 | -83.3% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 885900000.0 | +233.8% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 1592400000.0 | +79.7% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 581600000.0 | -63.5% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 1297000000.0 | +123.0% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 2138000000.0 | +64.8% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 1087000000.0 | — | USD | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 1143900000.0 | +5.2% | USD | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 1169600000.0 | +2.2% | USD | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 1598200000.0 | +36.6% | USD | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 1484800000.0 | -7.1% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 2089400000.0 | +40.7% | USD | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 1490800000.0 | -28.6% | USD | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 1813800000.0 | +21.7% | USD | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 2415000000.0 | +33.1% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 3030500000.0 | +25.5% | USD | 10-K | 2026-02-03 |
Investing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | -191900000.0 | — | USD | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | -429100000.0 | -123.6% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | -970400000.0 | -126.1% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 1308300000.0 | +234.8% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 954500000.0 | -27.0% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 694500000.0 | -27.2% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 53600000.0 | -92.3% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 9300000.0 | -82.6% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | -563300000.0 | -6157.0% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | -308900000.0 | +45.2% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | -531600000.0 | -72.1% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | -748200000.0 | -40.7% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | -117100000.0 | +84.3% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 419600000.0 | +458.3% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | -606300000.0 | -244.5% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | -597000000.0 | +1.5% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | -981700000.0 | -64.4% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | -1820500000.0 | -85.4% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | -214700000.0 | +88.2% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 251500000.0 | +217.1% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 796000000.0 | +216.5% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 573100000.0 | -28.0% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 1130700000.0 | +97.3% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 684100000.0 | -39.5% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | -128500000.0 | -118.8% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | -595600000.0 | -363.5% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | -2008600000.0 | -237.2% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 213500000.0 | +110.6% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 474200000.0 | +122.1% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 875200000.0 | +84.6% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | -1279400000.0 | — | USD | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 378700000.0 | +129.6% | USD | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | -1049600000.0 | -377.2% | USD | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | -1154400000.0 | -10.0% | USD | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | -940600000.0 | +18.5% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | -2461500000.0 | -161.7% | USD | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 1370800000.0 | +155.7% | USD | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | -360100000.0 | -126.3% | USD | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | -3272800000.0 | -808.9% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 665800000.0 | +120.3% | USD | 10-K | 2026-02-03 |
Financing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 230100000.0 | — | USD | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 418600000.0 | +81.9% | USD | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 519100000.0 | +24.0% | USD | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | -1878300000.0 | -461.8% | USD | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | -1753600000.0 | +6.6% | USD | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | -1670000000.0 | +4.8% | USD | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | -8300000.0 | +99.5% | USD | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 34900000.0 | +520.5% | USD | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 92600000.0 | +165.3% | USD | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | -41800000.0 | -145.1% | USD | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | -220400000.0 | -427.3% | USD | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | -219200000.0 | +0.5% | USD | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | -178700000.0 | +18.5% | USD | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | -131100000.0 | +26.6% | USD | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | -45900000.0 | +65.0% | USD | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | -102200000.0 | -122.7% | USD | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | -43900000.0 | +57.0% | USD | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 24400000.0 | +155.6% | USD | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | -199900000.0 | -919.3% | USD | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | -682000000.0 | -241.2% | USD | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | -1608800000.0 | -135.9% | USD | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | -381200000.0 | +76.3% | USD | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | -317900000.0 | +16.6% | USD | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | -256100000.0 | +19.4% | USD | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | -46700000.0 | +81.8% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 3300000.0 | +107.1% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 101500000.0 | +2975.8% | USD | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | -235800000.0 | -332.3% | USD | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | -383600000.0 | -62.7% | USD | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | -2226600000.0 | -480.4% | USD | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 514400000.0 | — | USD | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | -1913100000.0 | -471.9% | USD | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 126300000.0 | +106.6% | USD | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | -168400000.0 | -233.3% | USD | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | -85700000.0 | +49.1% | USD | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 43000000.0 | +150.2% | USD | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | -2572300000.0 | -6082.1% | USD | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | -287600000.0 | +88.8% | USD | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 150900000.0 | +152.5% | USD | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | -2364100000.0 | -1666.7% | USD | 10-K | 2026-02-03 |
Capital Expenditures
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Share Data
Metrics: 4Shares Outstanding
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 38100000.0 | — | shares | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 38500000.0 | +1.0% | shares | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 38700000.0 | +0.5% | shares | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 116400000.0 | +200.8% | shares | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 36800000.0 | -68.4% | shares | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 37100000.0 | +0.8% | shares | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 112000000.0 | +201.9% | shares | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 112300000.0 | +0.3% | shares | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 113300000.0 | +0.9% | shares | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 113700000.0 | +0.4% | shares | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 114200000.0 | +0.4% | shares | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 114500000.0 | +0.3% | shares | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 115400000.0 | +0.8% | shares | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 115200000.0 | -0.2% | shares | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 115600000.0 | +0.3% | shares | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 116000000.0 | +0.3% | shares | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 116600000.0 | +0.5% | shares | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 117000000.0 | +0.3% | shares | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 117500000.0 | +0.4% | shares | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 353100000.0 | +200.5% | shares | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 118400000.0 | -66.5% | shares | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 118700000.0 | +0.3% | shares | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 357200000.0 | +200.9% | shares | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 357700000.0 | +0.1% | shares | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 358900000.0 | +0.3% | shares | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 357100000.0 | -0.5% | shares | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 353300000.0 | -1.1% | shares | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 350000000.0 | -0.9% | shares | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 350400000.0 | +0.1% | shares | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 351300000.0 | +0.3% | shares | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 352000000.0 | +0.2% | shares | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 352300000.0 | +0.1% | shares | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 354700000.0 | +0.7% | shares | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 355300000.0 | +0.2% | shares | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 356200000.0 | +0.3% | shares | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 356600000.0 | +0.1% | shares | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 358400000.0 | +0.5% | shares | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 358400000.0 | +0.0% | shares | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 354900000.0 | -1.0% | shares | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 116400000.0 | — | shares | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 112300000.0 | -3.5% | shares | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 114500000.0 | +2.0% | shares | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 116000000.0 | +1.3% | shares | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 353100000.0 | +204.4% | shares | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 357700000.0 | +1.3% | shares | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 350000000.0 | -2.2% | shares | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 352300000.0 | +0.7% | shares | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 356600000.0 | +1.2% | shares | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 355100000.0 | -0.4% | shares | 10-K | 2026-02-03 |
Shares Issued
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-09-30 | 38700000.0 | — | shares | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 116400000.0 | +200.8% | shares | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 36800000.0 | -68.4% | shares | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 37100000.0 | +0.8% | shares | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 112000000.0 | +201.9% | shares | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 112300000.0 | +0.3% | shares | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 113300000.0 | +0.9% | shares | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 113700000.0 | +0.4% | shares | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 114200000.0 | +0.4% | shares | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 114500000.0 | +0.3% | shares | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 115400000.0 | +0.8% | shares | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 115200000.0 | -0.2% | shares | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 115600000.0 | +0.3% | shares | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 116000000.0 | +0.3% | shares | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 116600000.0 | +0.5% | shares | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 117000000.0 | +0.3% | shares | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 117500000.0 | +0.4% | shares | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 353100000.0 | +200.5% | shares | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 118400000.0 | -66.5% | shares | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 118700000.0 | +0.3% | shares | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 357200000.0 | +200.9% | shares | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 357700000.0 | +0.1% | shares | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 358900000.0 | +0.3% | shares | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 357100000.0 | -0.5% | shares | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 353300000.0 | -1.1% | shares | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 350000000.0 | -0.9% | shares | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 350400000.0 | +0.1% | shares | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 351300000.0 | +0.3% | shares | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 352000000.0 | +0.2% | shares | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 352300000.0 | +0.1% | shares | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 354700000.0 | +0.7% | shares | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 355300000.0 | +0.2% | shares | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 356200000.0 | +0.3% | shares | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 356600000.0 | +0.1% | shares | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 358400000.0 | +0.5% | shares | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 358400000.0 | +0.0% | shares | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 354900000.0 | -1.0% | shares | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 116400000.0 | — | shares | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 112300000.0 | -3.5% | shares | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 114500000.0 | +2.0% | shares | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 116000000.0 | +1.3% | shares | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 353100000.0 | +204.4% | shares | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 357700000.0 | +1.3% | shares | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 350000000.0 | -2.2% | shares | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 352300000.0 | +0.7% | shares | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 356600000.0 | +1.2% | shares | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 355100000.0 | -0.4% | shares | 10-K | 2026-02-03 |
Weighted Avg Shares Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 37700000.0 | — | shares | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 38300000.0 | +1.6% | shares | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 116100000.0 | +203.1% | shares | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 111900000.0 | -3.6% | shares | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 111000000.0 | -0.8% | shares | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 111800000.0 | +0.7% | shares | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 112800000.0 | +0.9% | shares | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 113500000.0 | +0.6% | shares | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 114000000.0 | +0.4% | shares | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 115000000.0 | +0.9% | shares | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 115400000.0 | +0.3% | shares | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 115400000.0 | +0.0% | shares | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 116400000.0 | +0.9% | shares | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 116800000.0 | +0.3% | shares | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 352000000.0 | +201.4% | shares | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 354200000.0 | +0.6% | shares | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 355700000.0 | +0.4% | shares | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 356800000.0 | +0.3% | shares | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 358400000.0 | +0.4% | shares | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 358100000.0 | -0.1% | shares | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 355300000.0 | -0.8% | shares | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 350200000.0 | -1.4% | shares | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 350900000.0 | +0.2% | shares | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 351700000.0 | +0.2% | shares | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 353500000.0 | +0.5% | shares | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 355000000.0 | +0.4% | shares | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 355800000.0 | +0.2% | shares | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 357500000.0 | +0.5% | shares | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 358500000.0 | +0.3% | shares | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 356600000.0 | -0.5% | shares | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 114900000.0 | — | shares | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 111700000.0 | -2.8% | shares | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 113700000.0 | +1.8% | shares | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 346200000.0 | +204.5% | shares | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 351100000.0 | +1.4% | shares | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 356100000.0 | +1.4% | shares | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 355700000.0 | -0.1% | shares | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 351200000.0 | -1.3% | shares | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 355200000.0 | +1.1% | shares | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 356900000.0 | +0.5% | shares | 10-K | 2026-02-03 |
Weighted Avg Shares Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 38500000.0 | — | shares | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 39200000.0 | +1.8% | shares | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 119100000.0 | +203.8% | shares | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 115500000.0 | -3.0% | shares | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 115200000.0 | -0.3% | shares | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 116800000.0 | +1.4% | shares | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 118000000.0 | +1.0% | shares | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 118500000.0 | +0.4% | shares | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 119200000.0 | +0.6% | shares | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 119600000.0 | +0.3% | shares | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 119300000.0 | -0.3% | shares | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 119300000.0 | +0.0% | shares | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 119800000.0 | +0.4% | shares | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 119700000.0 | -0.1% | shares | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 361900000.0 | +202.3% | shares | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 364000000.0 | +0.6% | shares | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 364900000.0 | +0.2% | shares | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 366800000.0 | +0.5% | shares | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 366700000.0 | -0.0% | shares | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 363900000.0 | -0.8% | shares | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 360500000.0 | -0.9% | shares | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 356000000.0 | -1.2% | shares | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 357300000.0 | +0.4% | shares | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 358200000.0 | +0.3% | shares | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 360500000.0 | +0.6% | shares | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 361000000.0 | +0.1% | shares | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 362700000.0 | +0.5% | shares | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 364600000.0 | +0.5% | shares | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 364100000.0 | -0.1% | shares | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 361800000.0 | -0.6% | shares | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 117900000.0 | — | shares | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 116300000.0 | -1.4% | shares | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 118800000.0 | +2.1% | shares | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 358400000.0 | +201.7% | shares | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 361000000.0 | +0.7% | shares | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 365800000.0 | +1.3% | shares | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 362000000.0 | -1.0% | shares | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 357400000.0 | -1.3% | shares | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 362000000.0 | +1.3% | shares | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 362700000.0 | +0.2% | shares | 10-K | 2026-02-03 |
Credit and Bond Coverage
Company-levelMetrics
Metrics: 9Asset Turnover
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.1120 | — | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 0.1159 | +3.5% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 0.1106 | -4.6% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 0.1413 | +27.8% | ratio | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 0.1445 | +2.2% | ratio | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 0.1431 | -1.0% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 0.1319 | -7.8% | ratio | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 0.1328 | +0.7% | ratio | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 0.1258 | -5.2% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 0.1182 | -6.0% | ratio | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 0.1288 | +8.9% | ratio | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 0.1236 | -4.1% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 0.1112 | -10.0% | ratio | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 0.0843 | -24.1% | ratio | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 0.1015 | +20.4% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 0.1120 | +10.3% | ratio | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 0.1191 | +6.3% | ratio | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 0.1085 | -8.9% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 0.1088 | +0.2% | ratio | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 0.1111 | +2.1% | ratio | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 0.1174 | +5.7% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 0.1299 | +10.6% | ratio | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 0.1263 | -2.8% | ratio | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 0.1185 | -6.2% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 0.1194 | +0.8% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 0.1207 | +1.1% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 0.1149 | -4.8% | ratio | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 0.1172 | +2.1% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 0.1210 | +3.2% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 0.1295 | +7.0% | ratio | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 0.4172 | — | ratio | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 0.5432 | +30.2% | ratio | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 0.4746 | -12.6% | ratio | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 0.4601 | -3.1% | ratio | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 0.3902 | -15.2% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.4213 | +8.0% | ratio | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 0.4796 | +13.8% | ratio | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 0.4614 | -3.8% | ratio | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 0.4456 | -3.4% | ratio | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 0.4920 | +10.4% | ratio | 10-K | 2026-02-03 |
Current Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 5.3133 | — | ratio | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 5.7761 | +8.7% | ratio | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 5.5130 | -4.6% | ratio | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 5.4491 | -1.2% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 3.8834 | -28.7% | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 4.4051 | +13.4% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 4.7570 | +8.0% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 4.2379 | -10.9% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 5.8185 | +37.3% | ratio | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 5.9815 | +2.8% | ratio | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 6.0466 | +1.1% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 5.2805 | -12.7% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 5.4377 | +3.0% | ratio | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 5.0422 | -7.3% | ratio | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 4.6374 | -8.0% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 4.5259 | -2.4% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 4.9598 | +9.6% | ratio | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 6.3787 | +28.6% | ratio | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 7.0418 | +10.4% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 6.8648 | -2.5% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 6.7062 | -2.3% | ratio | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 5.9891 | -10.7% | ratio | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 5.5758 | -6.9% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 5.0834 | -8.8% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 5.2178 | +2.6% | ratio | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 5.3553 | +2.6% | ratio | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 5.1022 | -4.7% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 4.3970 | -13.8% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 5.2601 | +19.6% | ratio | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 5.2209 | -0.7% | ratio | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 5.3107 | +1.7% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 4.7555 | -10.5% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 5.5507 | +16.7% | ratio | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 5.1457 | -7.3% | ratio | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 4.3032 | -16.4% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 4.0744 | -5.3% | ratio | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 4.9787 | +22.2% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 5.1671 | +3.8% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 4.7279 | -8.5% | ratio | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 5.4491 | — | ratio | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 4.2379 | -22.2% | ratio | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 5.2805 | +24.6% | ratio | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 4.5259 | -14.3% | ratio | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 6.8648 | +51.7% | ratio | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 5.0834 | -25.9% | ratio | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 4.3970 | -13.5% | ratio | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 4.7555 | +8.2% | ratio | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 4.0744 | -14.3% | ratio | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 4.8746 | +19.6% | ratio | 10-K | 2026-02-03 |
Debt to Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.1170 | — | ratio | 10-Q | 2016-04-19 |
| Quarterly | 2016-06-30 | 0.1157 | -1.2% | ratio | 10-Q | 2016-07-20 |
| Quarterly | 2016-09-30 | 0.1142 | -1.3% | ratio | 10-Q | 2016-10-19 |
| Quarterly | 2016-12-31 | 0.1227 | +7.5% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 0.1649 | +34.3% | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 0.1611 | -2.3% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 0.1380 | -14.3% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 0.2084 | +51.0% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 0.1670 | -19.9% | ratio | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 0.1670 | -0.0% | ratio | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 0.1638 | -1.9% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 0.1733 | +5.8% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 0.1697 | -2.1% | ratio | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 0.1720 | +1.4% | ratio | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 0.1741 | +1.2% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 0.1748 | +0.4% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 0.1595 | -8.8% | ratio | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 0.1525 | -4.4% | ratio | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 0.1433 | -6.1% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 0.1445 | +0.8% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 0.1325 | -8.3% | ratio | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 0.1303 | -1.7% | ratio | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 0.1287 | -1.2% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 0.1342 | +4.2% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 0.1252 | -6.7% | ratio | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 0.1343 | +7.3% | ratio | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 0.1457 | +8.5% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 0.1675 | +14.9% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 0.1557 | -7.0% | ratio | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 0.1625 | +4.3% | ratio | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 0.1655 | +1.8% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 0.1526 | -7.8% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 0.1268 | -16.9% | ratio | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 0.1253 | -1.2% | ratio | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 0.1318 | +5.2% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 0.1339 | +1.6% | ratio | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 0.1170 | -12.7% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 0.1231 | +5.2% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 0.1355 | +10.1% | ratio | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 0.1218 | — | ratio | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 0.2084 | +71.1% | ratio | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 0.1733 | -16.8% | ratio | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 0.1748 | +0.9% | ratio | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 0.1445 | -17.4% | ratio | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 0.1342 | -7.1% | ratio | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 0.1675 | +24.8% | ratio | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 0.1526 | -8.9% | ratio | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 0.1339 | -12.2% | ratio | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 0.1403 | +4.8% | ratio | 10-K | 2026-02-03 |
Gross Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.6812 | — | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 0.7027 | +3.2% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 0.7131 | +1.5% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 0.6913 | -3.1% | ratio | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 0.6986 | +1.1% | ratio | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 0.7033 | +0.7% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 0.7006 | -0.4% | ratio | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 0.6954 | -0.8% | ratio | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 0.6975 | +0.3% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 0.6877 | -1.4% | ratio | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 0.6907 | +0.4% | ratio | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 0.6963 | +0.8% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 0.6714 | -3.6% | ratio | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 0.5902 | -12.1% | ratio | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 0.6721 | +13.9% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 0.6986 | +3.9% | ratio | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 0.6992 | +0.1% | ratio | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 0.6922 | -1.0% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 0.6787 | -2.0% | ratio | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 0.6723 | -0.9% | ratio | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 0.6755 | +0.5% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 0.6562 | -2.9% | ratio | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 0.6674 | +1.7% | ratio | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 0.6694 | +0.3% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 0.6587 | -1.6% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 0.6830 | +3.7% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 0.6741 | -1.3% | ratio | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 0.6469 | -4.0% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 0.6631 | +2.5% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 0.6636 | +0.1% | ratio | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 0.6994 | — | ratio | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 0.7017 | +0.3% | ratio | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 0.6992 | -0.3% | ratio | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 0.6945 | -0.7% | ratio | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 0.6565 | -5.5% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.6932 | +5.6% | ratio | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 0.6744 | -2.7% | ratio | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 0.6639 | -1.6% | ratio | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 0.6746 | +1.6% | ratio | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 0.6600 | -2.2% | ratio | 10-K | 2026-02-03 |
Net Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.2294 | — | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 0.2753 | +20.0% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 0.3090 | +12.2% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 0.2660 | -13.9% | ratio | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 0.2939 | +10.5% | ratio | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 0.3696 | +25.8% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 0.3390 | -8.3% | ratio | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 0.2800 | -17.4% | ratio | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 0.3169 | +13.2% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 0.3122 | -1.5% | ratio | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 0.2879 | -7.8% | ratio | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 0.3534 | +22.7% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 0.2876 | -18.6% | ratio | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 0.0824 | -71.4% | ratio | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 0.2940 | +256.8% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 0.3368 | +14.6% | ratio | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 0.3572 | +6.1% | ratio | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 0.2759 | -22.8% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 0.2483 | -10.0% | ratio | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 0.2060 | -17.0% | ratio | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 0.2085 | +1.2% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 0.2127 | +2.0% | ratio | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 0.2426 | +14.1% | ratio | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 0.2408 | -0.8% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 0.2895 | +20.3% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 0.2644 | -8.7% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 0.2800 | +5.9% | ratio | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 0.3123 | +11.5% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 0.2722 | -12.8% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 0.2831 | +4.0% | ratio | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 0.2728 | — | ratio | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 0.2138 | -21.6% | ratio | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 0.3021 | +41.3% | ratio | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 0.3085 | +2.1% | ratio | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 0.2448 | -20.7% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.3026 | +23.6% | ratio | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 0.2161 | -28.6% | ratio | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 0.2551 | +18.1% | ratio | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 0.2799 | +9.7% | ratio | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 0.2858 | +2.1% | ratio | 10-K | 2026-02-03 |
Operating Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.3011 | — | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 0.3662 | +21.6% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 0.3755 | +2.5% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 0.2846 | -24.2% | ratio | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 0.3425 | +20.4% | ratio | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 0.3474 | +1.4% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 0.3265 | -6.0% | ratio | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 0.3051 | -6.6% | ratio | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 0.3402 | +11.5% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 0.2590 | -23.9% | ratio | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 0.3267 | +26.1% | ratio | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 0.3241 | -0.8% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 0.2574 | -20.6% | ratio | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 0.0946 | -63.3% | ratio | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 0.2509 | +165.3% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 0.3226 | +28.6% | ratio | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 0.3492 | +8.2% | ratio | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 0.3154 | -9.7% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 0.2743 | -13.0% | ratio | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 0.2612 | -4.8% | ratio | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 0.2561 | -1.9% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 0.2285 | -10.8% | ratio | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 0.2638 | +15.4% | ratio | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 0.2671 | +1.3% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 0.2483 | -7.1% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 0.2823 | +13.7% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 0.2833 | +0.4% | ratio | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 0.2565 | -9.4% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 0.3047 | +18.8% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 0.3033 | -0.5% | ratio | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 0.3509 | — | ratio | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 0.3387 | -3.5% | ratio | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 0.3221 | -4.9% | ratio | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 0.3069 | -4.7% | ratio | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 0.2409 | -21.5% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.3189 | +32.4% | ratio | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 0.2535 | -20.5% | ratio | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 0.2480 | -2.2% | ratio | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 0.2812 | +13.4% | ratio | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 0.2927 | +4.1% | ratio | 10-K | 2026-02-03 |
Quick Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 2.1649 | — | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 2.4382 | +12.6% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 1.9345 | -20.7% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2016-12-31 | 1.7378 | -10.2% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 1.2694 | -27.0% | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2017-06-30 | 1.1612 | -8.5% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2017-09-30 | 1.4211 | +22.4% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-12-31 | 0.9780 | -31.2% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 1.6770 | +71.5% | ratio | 10-Q | 2018-04-18 |
| Quarterly | 2018-06-30 | 1.8060 | +7.7% | ratio | 10-Q | 2018-07-20 |
| Quarterly | 2018-09-30 | 1.4337 | -20.6% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-12-31 | 1.0455 | -27.1% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 1.1831 | +13.2% | ratio | 10-Q | 2019-04-19 |
| Quarterly | 2019-06-30 | 0.9787 | -17.3% | ratio | 10-Q | 2019-07-22 |
| Quarterly | 2019-09-30 | 1.0416 | +6.4% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-12-31 | 1.1334 | +8.8% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 1.2938 | +14.2% | ratio | 10-Q | 2020-04-17 |
| Quarterly | 2020-06-30 | 2.2011 | +70.1% | ratio | 10-Q | 2020-07-23 |
| Quarterly | 2020-09-30 | 1.5319 | -30.4% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-12-31 | 1.6811 | +9.7% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 1.5496 | -7.8% | ratio | 10-Q | 2021-04-21 |
| Quarterly | 2021-06-30 | 1.6081 | +3.8% | ratio | 10-Q | 2021-07-21 |
| Quarterly | 2021-09-30 | 1.3109 | -18.5% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-12-31 | 1.1227 | -14.4% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 0.9918 | -11.7% | ratio | 10-Q | 2022-04-22 |
| Quarterly | 2022-06-30 | 1.3073 | +31.8% | ratio | 10-Q | 2022-07-22 |
| Quarterly | 2022-09-30 | 1.2470 | -4.6% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-12-31 | 1.1119 | -10.8% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 1.6391 | +47.4% | ratio | 10-Q | 2023-04-20 |
| Quarterly | 2023-06-30 | 2.2331 | +36.2% | ratio | 10-Q | 2023-07-24 |
| Quarterly | 2023-09-30 | 2.1487 | -3.8% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-12-31 | 1.6580 | -22.8% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 2.0649 | +24.5% | ratio | 10-Q | 2024-04-19 |
| Quarterly | 2024-06-30 | 2.0415 | -1.1% | ratio | 10-Q | 2024-07-19 |
| Quarterly | 2024-09-30 | 1.4392 | -29.5% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-12-31 | 1.1616 | -19.3% | ratio | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 1.6734 | +44.1% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 2.0106 | +20.2% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 1.5565 | -22.6% | ratio | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 1.7378 | — | ratio | 10-K | 2018-02-02 |
| Annual | 2017-12-31 | 0.9780 | -43.7% | ratio | 10-K | 2019-02-04 |
| Annual | 2018-12-31 | 1.0455 | +6.9% | ratio | 10-K | 2020-02-07 |
| Annual | 2019-12-31 | 1.1334 | +8.4% | ratio | 10-K | 2021-02-10 |
| Annual | 2020-12-31 | 1.6811 | +48.3% | ratio | 10-K | 2022-02-03 |
| Annual | 2021-12-31 | 1.1227 | -33.2% | ratio | 10-K | 2023-02-10 |
| Annual | 2022-12-31 | 1.1119 | -1.0% | ratio | 10-K | 2024-01-31 |
| Annual | 2023-12-31 | 1.6580 | +49.1% | ratio | 10-K | 2025-01-31 |
| Annual | 2024-12-31 | 1.1616 | -29.9% | ratio | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 1.6788 | +44.5% | ratio | 10-K | 2026-02-03 |
ROA
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.0257 | — | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 0.0319 | +24.2% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 0.0342 | +7.1% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 0.0376 | +10.0% | ratio | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 0.0425 | +12.9% | ratio | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 0.0529 | +24.6% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 0.0447 | -15.5% | ratio | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 0.0372 | -16.9% | ratio | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 0.0399 | +7.3% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 0.0369 | -7.4% | ratio | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 0.0371 | +0.5% | ratio | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 0.0437 | +17.7% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 0.0320 | -26.8% | ratio | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 0.0069 | -78.3% | ratio | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 0.0298 | +329.4% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 0.0377 | +26.4% | ratio | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 0.0425 | +12.8% | ratio | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 0.0299 | -29.6% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 0.0270 | -9.8% | ratio | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 0.0229 | -15.3% | ratio | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 0.0245 | +7.0% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 0.0276 | +12.9% | ratio | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 0.0306 | +10.9% | ratio | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 0.0285 | -6.9% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 0.0346 | +21.2% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 0.0319 | -7.7% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 0.0322 | +0.7% | ratio | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 0.0366 | +13.8% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 0.0329 | -10.0% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 0.0366 | +11.3% | ratio | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 0.1138 | — | ratio | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 0.1161 | +2.0% | ratio | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 0.1434 | +23.5% | ratio | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 0.1420 | -1.0% | ratio | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 0.0955 | -32.7% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.1275 | +33.5% | ratio | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 0.1036 | -18.7% | ratio | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 0.1177 | +13.6% | ratio | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 0.1247 | +6.0% | ratio | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 0.1406 | +12.7% | ratio | 10-K | 2026-02-03 |
ROE
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.0287 | — | ratio | 10-Q | 2017-04-19 |
| Quarterly | 2016-06-30 | 0.0356 | +24.0% | ratio | 10-Q | 2017-07-21 |
| Quarterly | 2016-09-30 | 0.0381 | +6.9% | ratio | 10-Q | 2017-10-20 |
| Quarterly | 2017-03-31 | 0.0438 | +15.0% | ratio | 10-Q | 2018-04-18 |
| Quarterly | 2017-06-30 | 0.0493 | +12.6% | ratio | 10-Q | 2018-07-20 |
| Quarterly | 2017-09-30 | 0.0602 | +22.1% | ratio | 10-Q | 2018-10-22 |
| Quarterly | 2018-03-31 | 0.0522 | -13.3% | ratio | 10-Q | 2019-04-19 |
| Quarterly | 2018-06-30 | 0.0434 | -16.9% | ratio | 10-Q | 2019-07-22 |
| Quarterly | 2018-09-30 | 0.0464 | +7.0% | ratio | 10-Q | 2019-10-18 |
| Quarterly | 2019-03-31 | 0.0432 | -6.9% | ratio | 10-Q | 2020-04-17 |
| Quarterly | 2019-06-30 | 0.0435 | +0.7% | ratio | 10-Q | 2020-07-23 |
| Quarterly | 2019-09-30 | 0.0513 | +18.0% | ratio | 10-Q | 2020-10-19 |
| Quarterly | 2020-03-31 | 0.0371 | -27.7% | ratio | 10-Q | 2021-04-21 |
| Quarterly | 2020-06-30 | 0.0080 | -78.4% | ratio | 10-Q | 2021-07-21 |
| Quarterly | 2020-09-30 | 0.0341 | +326.0% | ratio | 10-Q | 2021-10-20 |
| Quarterly | 2021-03-31 | 0.0427 | +25.2% | ratio | 10-Q | 2022-04-22 |
| Quarterly | 2021-06-30 | 0.0481 | +12.6% | ratio | 10-Q | 2022-07-22 |
| Quarterly | 2021-09-30 | 0.0338 | -29.7% | ratio | 10-Q | 2022-10-21 |
| Quarterly | 2022-03-31 | 0.0304 | -10.1% | ratio | 10-Q | 2023-04-20 |
| Quarterly | 2022-06-30 | 0.0260 | -14.6% | ratio | 10-Q | 2023-07-24 |
| Quarterly | 2022-09-30 | 0.0281 | +8.1% | ratio | 10-Q | 2023-10-20 |
| Quarterly | 2023-03-31 | 0.0319 | +13.9% | ratio | 10-Q | 2024-04-19 |
| Quarterly | 2023-06-30 | 0.0356 | +11.5% | ratio | 10-Q | 2024-07-19 |
| Quarterly | 2023-09-30 | 0.0333 | -6.6% | ratio | 10-Q | 2024-10-18 |
| Quarterly | 2024-03-31 | 0.0390 | +17.2% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2024-06-30 | 0.0359 | -7.8% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2024-09-30 | 0.0364 | +1.3% | ratio | 10-Q | 2025-10-22 |
| Quarterly | 2025-03-31 | 0.0409 | +12.4% | ratio | 10-Q | 2025-04-23 |
| Quarterly | 2025-06-30 | 0.0370 | -9.5% | ratio | 10-Q | 2025-07-23 |
| Quarterly | 2025-09-30 | 0.0416 | +12.5% | ratio | 10-Q | 2025-10-22 |
| Annual | 2016-12-31 | 0.1268 | — | ratio | 10-K | 2019-02-04 |
| Annual | 2017-12-31 | 0.1403 | +10.6% | ratio | 10-K | 2020-02-07 |
| Annual | 2018-12-31 | 0.1682 | +19.9% | ratio | 10-K | 2021-02-10 |
| Annual | 2019-12-31 | 0.1668 | -0.9% | ratio | 10-K | 2022-02-03 |
| Annual | 2020-12-31 | 0.1093 | -34.5% | ratio | 10-K | 2023-02-10 |
| Annual | 2021-12-31 | 0.1446 | +32.3% | ratio | 10-K | 2024-01-31 |
| Annual | 2022-12-31 | 0.1210 | -16.3% | ratio | 10-K | 2025-01-31 |
| Annual | 2023-12-31 | 0.1356 | +12.1% | ratio | 10-K | 2026-02-03 |
| Annual | 2024-12-31 | 0.1414 | +4.3% | ratio | 10-K | 2026-02-03 |
| Annual | 2025-12-31 | 0.1603 | +13.4% | ratio | 10-K | 2026-02-03 |
8-K Material Event Details
This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.
Event Type Distribution
Count per 8-K itemInsider Transaction History
Net Insider Flow
Monthly open-market buy value minus open-market sell valueMonthly Insider Activity Mix
Share volume split between open-market trades, grants, and exercisesTransaction Value Timeline
All Transactions
| Date | Insider | Title | Type | Security | Shares | Price | Total Value | Post-Tx Shares |
|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 105 | $0.00 | $0 | 1,152 |
| 2026-03-10 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 105 | $493.95 | $51,865 | 0 |
| 2026-03-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 105 | $229.39 | $24,086 | 105 |
| 2026-03-09 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 645 | $485.01 | $312,831 | 1,613 |
| 2026-03-06 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 648 | $490.19 | $317,643 | 2,258 |
| 2026-03-05 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 648 | $495.20 | $320,890 | 2,906 |
| 2026-03-04 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 2,362 | $498.68 | $1,177,883 | 3,554 |
| 2026-03-03 | Widman Fredrik | VP Corporate Controller |
Open-market sell
S
|
Common Stock | 118 | $487.18 | $57,487 | 1,026 |
| 2026-03-03 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 4,728 | $487.18 | $2,303,387 | 409 |
| 2026-03-03 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 648 | $488.10 | $316,289 | 5,916 |
| 2026-03-02 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 125 | $0.00 | $0 | 0 |
| 2026-03-02 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 125 | $492.59 | $61,574 | 5,137 |
| 2026-03-02 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 125 | $208.90 | $26,112 | 5,262 |
| 2026-02-28 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 468 | $0.00 | $0 | 0 |
| 2026-02-28 | Widman Fredrik | VP Corporate Controller |
Other disposed transaction
F
|
Common Stock | 233 | $503.51 | $117,318 | 1,144 |
| 2026-02-28 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M
|
Common Stock | 468 | $0.00 | $0 | 1,377 |
| 2026-02-28 | Jeddi Iman | SVP & GM da Vinci Platforms & |
Exercise / conversion
M · derivative
|
Restricted Stock Units - 2-28-2022 | 626 | $0.00 | $0 | 0 |
| 2026-02-28 | Jeddi Iman | SVP & GM da Vinci Platforms & |
Exercise / conversion
M · derivative
|
Performance Stock Units - 2-28-2023 | 8,378 | $0.00 | $0 | 0 |
| 2026-02-28 | Jeddi Iman | SVP & GM da Vinci Platforms & |
Other disposed transaction
F
|
Common Stock | 4,155 | $503.51 | $2,092,084 | 6,463 |
| 2026-02-28 | Jeddi Iman | SVP & GM da Vinci Platforms & |
Exercise / conversion
M
|
Common Stock | 8,378 | $0.00 | $0 | 10,618 |
| 2026-02-28 | Jeddi Iman | SVP & GM da Vinci Platforms & |
Other disposed transaction
F
|
Common Stock | 311 | $503.51 | $156,592 | 2,240 |
| 2026-02-28 | Jeddi Iman | SVP & GM da Vinci Platforms & |
Exercise / conversion
M
|
Common Stock | 626 | $0.00 | $0 | 2,551 |
| 2026-02-27 | WADORS PATRICIA L | SVP Chief Human Resources Offi |
Open-market sell
S
|
Common Stock | 220 | $499.71 | $109,936 | 0 |
| 2026-02-27 | Widman Fredrik | VP Corporate Controller |
Open-market sell
S
|
Common Stock | 249 | $499.71 | $124,428 | 909 |
| 2026-02-26 | WADORS PATRICIA L | SVP Chief Human Resources Offi |
Equity grant / award
A · derivative
|
Restricted Stock Units - 2-26-2026 | 3,584 | $0.00 | $0 | 3,584 |
| 2026-02-26 | WADORS PATRICIA L | SVP Chief Human Resources Offi |
Exercise / conversion
M · derivative
|
Restricted Stock Units - 2-26-2025 | 458 | $0.00 | $0 | 1,373 |
| 2026-02-26 | WADORS PATRICIA L | SVP Chief Human Resources Offi |
Other disposed transaction
F
|
Common Stock | 238 | $506.17 | $120,468 | 220 |
| 2026-02-26 | WADORS PATRICIA L | SVP Chief Human Resources Offi |
Exercise / conversion
M
|
Common Stock | 458 | $0.00 | $0 | 458 |
| 2026-02-11 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 421 | $494.96 | $208,378 | 409 |
| 2026-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 838 | $0.00 | $0 | 838 |
| 2026-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 105 | $0.00 | $0 | 1,257 |
| 2026-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 105 | $494.65 | $51,938 | 830 |
| 2026-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 105 | $229.39 | $24,086 | 935 |
| 2026-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 417 | $492.84 | $205,514 | 830 |
| 2026-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 838 | $0.00 | $0 | 1,247 |
| 2026-01-29 | Leonard Keith R | Dir |
Other disposed transaction
J
|
Common Stock | 369 | $0.00 | $0 | 370 |
| 2026-01-28 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Equity grant / award
A · derivative
|
Performance Stock Units - 2-28-2023 | 5,585 | $0.00 | $0 | 5,585 |
| 2026-01-28 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Equity grant / award
A · derivative
|
Performance Stock Units - 2-26-2024 | 2,702 | $0.00 | $0 | 2,702 |
| 2026-01-27 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 105 | $0.00 | $0 | 1,362 |
| 2026-01-27 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 125 | $0.00 | $0 | 251 |
| 2026-01-27 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 125 | $532.61 | $66,576 | 0 |
| 2026-01-27 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 125 | $208.90 | $26,112 | 125 |
| 2026-01-27 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 105 | $532.61 | $55,924 | 0 |
| 2026-01-27 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 105 | $229.39 | $24,086 | 105 |
| 2025-12-15 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 464 | $548.49 | $254,499 | 443 |
| 2025-12-15 | Brosius Mark | See Remarks |
Open-market sell
S
|
Common Stock | 464 | $548.49 | $254,499 | 131 |
| 2025-12-12 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 4,500 | $0.00 | $0 | 0 |
| 2025-12-12 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 4,500 | $547.36 | $2,463,120 | 907 |
| 2025-12-12 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Exercise / conversion
M
|
Common Stock | 4,500 | $79.64 | $358,370 | 5,407 |
| 2025-12-12 | Brosius Mark | See Remarks |
Open-market sell
S
|
Common Stock | 312 | $547.36 | $170,776 | 595 |
| 2025-12-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 104 | $0.00 | $0 | 1,467 |
| 2025-12-10 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 104 | $559.90 | $58,230 | 0 |
| 2025-12-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 104 | $229.39 | $23,857 | 104 |
| 2025-12-01 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 125 | $0.00 | $0 | 376 |
| 2025-12-01 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 125 | $568.99 | $71,124 | 0 |
| 2025-12-01 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 125 | $208.90 | $26,112 | 125 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 636 | $0.00 | $0 | 1,929 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,565 | $0.00 | $0 | 0 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,898 | $0.00 | $0 | 0 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,901 | $0.00 | $0 | 0 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 4,731 | $580.00 | $2,743,980 | 3,056 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 2,901 | $580.00 | $1,682,580 | 7,787 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 2,901 | $177.99 | $516,339 | 10,688 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 2,898 | $580.00 | $1,680,840 | 7,787 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 2,898 | $242.34 | $702,292 | 10,685 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 2,565 | $580.00 | $1,487,700 | 7,787 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 2,565 | $245.60 | $629,964 | 10,352 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 636 | $580.00 | $368,880 | 7,787 |
| 2025-11-12 | Charlton Henry L | EVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 636 | $347.42 | $220,957 | 8,423 |
| 2025-11-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 105 | $0.00 | $0 | 1,571 |
| 2025-11-10 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 105 | $560.00 | $58,800 | 0 |
| 2025-11-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 105 | $229.39 | $24,086 | 105 |
| 2025-11-05 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,908 | $0.00 | $0 | 0 |
| 2025-11-05 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 159 | $0.00 | $0 | 0 |
| 2025-11-05 | Widman Fredrik | VP Corporate Controller |
Open-market sell
S
|
Common Stock | 159 | $550.00 | $87,450 | 473 |
| 2025-11-05 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M
|
Common Stock | 159 | $59.46 | $9,454 | 632 |
| 2025-11-05 | Widman Fredrik | VP Corporate Controller |
Open-market sell
S
|
Common Stock | 1,908 | $550.00 | $1,049,400 | 473 |
| 2025-11-05 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M
|
Common Stock | 1,908 | $77.00 | $146,914 | 2,381 |
| 2025-11-03 | Rosa David J. | Chief Executive Officer (CEO) |
Equity grant / award
G
|
Common Stock | 5,454 | $0.00 | $0 | 228,802 |
| 2025-10-29 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 125 | $0.00 | $0 | 501 |
| 2025-10-29 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 125 | $543.00 | $67,875 | 0 |
| 2025-10-29 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 125 | $208.90 | $26,112 | 125 |
| 2025-10-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 5,030 | $0.00 | $0 | 0 |
| 2025-10-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,153 | $0.00 | $0 | 1,676 |
| 2025-10-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,379 | $0.00 | $0 | 626 |
| 2025-10-28 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,379 | $548.43 | $756,279 | 353 |
| 2025-10-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,379 | $208.90 | $288,073 | 1,732 |
| 2025-10-28 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,153 | $548.43 | $632,334 | 353 |
| 2025-10-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,153 | $229.39 | $264,487 | 1,506 |
| 2025-10-28 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 5,030 | $548.43 | $2,758,580 | 353 |
| 2025-10-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 5,030 | $242.34 | $1,218,954 | 5,383 |
| 2025-10-24 | GUTHART GARY S | Executive Chair of the Board o |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 36,000 | $0.00 | $0 | 0 |
| 2025-10-24 | GUTHART GARY S | Executive Chair of the Board o |
Open-market sell
S
|
Common Stock | 1,400 | $546.18 | $764,658 | 17,120 |
| 2025-10-24 | GUTHART GARY S | Executive Chair of the Board o |
Open-market sell
S
|
Common Stock | 28,800 | $547.56 | $15,769,644 | 27,027 |
| 2025-10-24 | GUTHART GARY S | Executive Chair of the Board o |
Exercise / conversion
M
|
Common Stock | 36,000 | $109.49 | $3,941,482 | 55,827 |
| 2025-10-10 | LOEB GARY | EVP & Chief Legal and Complian |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,612 | $0.00 | $0 | 2,612 |
| 2025-10-10 | LOEB GARY | EVP & Chief Legal and Complian |
Other disposed transaction
F
|
Common Stock | 1,296 | $443.76 | $575,113 | 3,561 |
| 2025-10-10 | LOEB GARY | EVP & Chief Legal and Complian |
Exercise / conversion
M
|
Common Stock | 2,612 | $0.00 | $0 | 4,857 |
| 2025-09-04 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 335 | $440.69 | $147,631 | 739 |
| 2025-09-03 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 336 | $470.11 | $157,957 | 1,074 |
| 2025-08-29 | GUTHART GARY S | Executive Chair of the Board o |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 36,000 | $0.00 | $0 | 0 |
| 2025-08-29 | GUTHART GARY S | Executive Chair of the Board o |
Open-market sell
S
|
Common Stock | 29,360 | $472.49 | $13,872,227 | 19,827 |
| 2025-08-29 | GUTHART GARY S | Executive Chair of the Board o |
Exercise / conversion
M
|
Common Stock | 36,000 | $79.64 | $2,866,961 | 49,187 |
| 2025-07-28 | GUTHART GARY S | Executive Chair of the Board o |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,893 | $0.00 | $0 | 0 |
| 2025-07-28 | GUTHART GARY S | Executive Chair of the Board o |
Equity grant / award
G
|
Common Stock | 10,500 | $0.00 | $0 | 1,204,863 |
| 2025-07-28 | GUTHART GARY S | Executive Chair of the Board o |
Open-market sell
S
|
Common Stock | 1,400 | $495.24 | $693,337 | 18,520 |
| 2025-07-28 | GUTHART GARY S | Executive Chair of the Board o |
Open-market sell
S
|
Common Stock | 7,893 | $498.64 | $3,935,756 | 13,187 |
| 2025-07-28 | GUTHART GARY S | Executive Chair of the Board o |
Exercise / conversion
M
|
Common Stock | 7,893 | $59.46 | $469,335 | 21,080 |
| 2025-07-25 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 4,500 | $0.00 | $0 | 5,030 |
| 2025-07-25 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 4,500 | $492.48 | $2,216,160 | 353 |
| 2025-07-25 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 4,500 | $242.34 | $1,090,515 | 4,853 |
| 2025-07-10 | Rosa David J. | Chief Executive Officer (CEO) |
Equity grant / award
A · derivative
|
Restricted Stock Units | 7,640 | $0.00 | $0 | 7,640 |
| 2025-06-10 | Rosa David J. | President |
Exercise / conversion
M · derivative
|
Restricted Stock Units - 6-12-23 | 1,358 | $0.00 | $0 | 2,716 |
| 2025-06-10 | Rosa David J. | President |
Other disposed transaction
F
|
Common Stock | 674 | $526.15 | $354,625 | 231,756 |
| 2025-06-10 | Rosa David J. | President |
Exercise / conversion
M
|
Common Stock | 1,358 | $0.00 | $0 | 232,430 |
| 2025-06-06 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 216 | $563.11 | $121,632 | 907 |
| 2025-06-05 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 215 | $560.70 | $120,550 | 1,123 |
| 2025-06-04 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 215 | $552.07 | $118,695 | 1,338 |
| 2025-06-04 | Rosa David J. | President |
Equity grant / award
G
|
Common Stock | 851 | $0.00 | $0 | 231,072 |
| 2025-06-03 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 215 | $550.68 | $118,396 | 1,553 |
| 2025-06-02 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 215 | $549.06 | $118,048 | 1,768 |
| 2025-05-16 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 20 | $563.81 | $11,276 | 1,983 |
| 2025-05-15 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 22 | $560.00 | $12,320 | 2,003 |
| 2025-05-14 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 22 | $563.00 | $12,386 | 2,025 |
| 2025-05-13 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 22 | $561.67 | $12,357 | 2,047 |
| 2025-05-12 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 22 | $551.97 | $12,143 | 2,069 |
| 2025-05-02 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 270 | $0.00 | $0 | 2,962 |
| 2025-05-02 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 269 | $0.00 | $0 | 2,963 |
| 2025-05-02 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 940 |
| 2025-05-02 | Samath Jamie | See Remarks |
Open-market sell
S
|
Common Stock | 915 | $527.95 | $483,074 | 7,162 |
| 2025-05-02 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 270 | $304.67 | $82,261 | 8,077 |
| 2025-05-02 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 269 | $229.39 | $61,706 | 7,619 |
| 2025-05-02 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 188 | $290.33 | $54,582 | 7,807 |
| 2025-05-01 | Ladd Amy L | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 531 | $0.00 | $0 | 531 |
| 2025-05-01 | Reed Monica P | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 531 | $0.00 | $0 | 531 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,709 | $0.00 | $0 | 0 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,671 | $0.00 | $0 | 0 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,448 | $0.00 | $0 | 0 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,650 | $0.00 | $0 | 0 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,298 | $0.00 | $0 | 0 |
| 2025-04-30 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 1,709 | $505.55 | $863,978 | 1,410 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M
|
Common Stock | 1,709 | $295.92 | $505,727 | 3,119 |
| 2025-04-30 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 1,650 | $505.55 | $834,151 | 1,410 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M
|
Common Stock | 1,650 | $171.20 | $282,480 | 3,060 |
| 2025-04-30 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 2,298 | $505.55 | $1,161,744 | 1,410 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M
|
Common Stock | 2,298 | $171.07 | $393,126 | 3,708 |
| 2025-04-30 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 1,671 | $505.55 | $844,767 | 1,410 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M
|
Common Stock | 1,671 | $286.55 | $478,831 | 3,081 |
| 2025-04-30 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 1,448 | $505.55 | $732,030 | 1,410 |
| 2025-04-30 | Ladd Amy L | Dir |
Exercise / conversion
M
|
Common Stock | 1,448 | $243.26 | $352,240 | 2,858 |
| 2025-04-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 1,880 |
| 2025-04-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $512.90 | $96,425 | 5,224 |
| 2025-04-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,412 |
| 2025-04-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 1,880 |
| 2025-04-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $515.91 | $96,991 | 5,224 |
| 2025-04-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $290.33 | $54,582 | 5,412 |
| 2025-04-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 119 | $0.00 | $0 | 2,634 |
| 2025-04-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 2,068 |
| 2025-04-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 119 | $513.18 | $61,068 | 5,224 |
| 2025-04-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 119 | $229.39 | $27,297 | 5,343 |
| 2025-04-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $513.18 | $96,478 | 5,224 |
| 2025-04-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,412 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 479 | $0.00 | $0 | 2,753 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 597 | $0.00 | $0 | 0 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 480 | $0.00 | $0 | 2,753 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 564 | $0.00 | $0 | 2,256 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 4,557 | $500.00 | $2,278,500 | 5,224 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 3,707 | $498.71 | $1,848,718 | 9,781 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 480 | $498.71 | $239,381 | 13,488 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 480 | $229.39 | $110,107 | 13,968 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 479 | $498.71 | $238,882 | 13,488 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 479 | $304.67 | $145,937 | 13,967 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 597 | $498.71 | $297,730 | 13,488 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 597 | $245.60 | $146,623 | 14,085 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 564 | $498.71 | $281,272 | 13,488 |
| 2025-03-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 564 | $208.90 | $117,820 | 14,052 |
| 2025-03-12 | Miller Brian Edward | EVP & Chief Digital Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,450 | $0.00 | $0 | 4,317 |
| 2025-03-12 | Miller Brian Edward | EVP & Chief Digital Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,550 | $0.00 | $0 | 0 |
| 2025-03-12 | Miller Brian Edward | EVP & Chief Digital Officer |
Open-market sell
S
|
Common Stock | 2,450 | $512.06 | $1,254,547 | 5,758 |
| 2025-03-12 | Miller Brian Edward | EVP & Chief Digital Officer |
Exercise / conversion
M
|
Common Stock | 2,450 | $208.90 | $511,805 | 8,208 |
| 2025-03-12 | Miller Brian Edward | EVP & Chief Digital Officer |
Open-market sell
S
|
Common Stock | 1,550 | $512.06 | $793,693 | 5,758 |
| 2025-03-12 | Miller Brian Edward | EVP & Chief Digital Officer |
Exercise / conversion
M
|
Common Stock | 1,550 | $177.99 | $275,879 | 7,308 |
| 2025-03-11 | Miller Brian Edward | EVP & Chief Digital Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,834 | $0.00 | $0 | 1,550 |
| 2025-03-11 | Miller Brian Edward | EVP & Chief Digital Officer |
Open-market sell
S
|
Common Stock | 6,624 | $484.97 | $3,212,449 | 5,758 |
| 2025-03-11 | Miller Brian Edward | EVP & Chief Digital Officer |
Open-market sell
S
|
Common Stock | 442 | $482.82 | $213,408 | 12,382 |
| 2025-03-11 | Miller Brian Edward | EVP & Chief Digital Officer |
Open-market sell
S
|
Common Stock | 1,834 | $485.96 | $891,245 | 12,824 |
| 2025-03-11 | Miller Brian Edward | EVP & Chief Digital Officer |
Exercise / conversion
M
|
Common Stock | 1,834 | $177.99 | $326,428 | 14,658 |
| 2025-03-07 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 489 | $533.18 | $260,725 | 2,091 |
| 2025-03-06 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 492 | $558.95 | $275,003 | 2,580 |
| 2025-03-05 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 492 | $554.17 | $272,652 | 3,072 |
| 2025-03-05 | Rosa David J. | President |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 14,625 | $0.00 | $0 | 0 |
| 2025-03-05 | Rosa David J. | President |
Open-market sell
S
|
Common Stock | 8,140 | $557.58 | $4,538,691 | 231,923 |
| 2025-03-05 | Rosa David J. | President |
Open-market sell
S
|
Common Stock | 8,369 | $557.47 | $4,665,452 | 225,438 |
| 2025-03-05 | Rosa David J. | President |
Exercise / conversion
M
|
Common Stock | 14,625 | $59.46 | $869,635 | 240,063 |
| 2025-03-04 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 492 | $563.69 | $277,335 | 3,564 |
| 2025-03-03 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 492 | $573.78 | $282,300 | 4,056 |
| 2025-03-03 | Widman Fredrik | VP Corporate Controller |
Open-market sell
S
|
Common Stock | 810 | $573.78 | $464,762 | 473 |
| 2025-02-28 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Exercise / conversion
M · derivative
|
Restricted Stock Units - 2-28-2022 | 877 | $0.00 | $0 | 877 |
| 2025-02-28 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Other disposed transaction
F
|
Common Stock | 2,175 | $563.77 | $1,226,200 | 4,548 |
| 2025-02-28 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Other disposed transaction
F
|
Common Stock | 435 | $563.77 | $245,240 | 6,723 |
| 2025-02-28 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Exercise / conversion
M
|
Common Stock | 877 | $0.00 | $0 | 7,158 |
| 2025-02-28 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 468 | $0.00 | $0 | 468 |
| 2025-02-28 | Widman Fredrik | VP Corporate Controller |
Other disposed transaction
F
|
Common Stock | 233 | $563.77 | $131,358 | 1,283 |
| 2025-02-28 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M
|
Common Stock | 468 | $0.00 | $0 | 1,516 |
| 2025-02-27 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Equity grant / award
A
|
Common Stock | 4,385 | $0.00 | $0 | 6,281 |
| 2025-02-26 | Rosa David J. | President |
Equity grant / award
A · derivative
|
Restricted Stock Units - 2-26-2025 | 9,155 | $0.00 | $0 | 9,155 |
| 2025-02-26 | Rosa David J. | President |
Exercise / conversion
M · derivative
|
Restricted Stock Units - 2-26-2024 | 3,816 | $0.00 | $0 | 11,447 |
| 2025-02-26 | Rosa David J. | President |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,710 | $0.00 | $0 | 0 |
| 2025-02-26 | Rosa David J. | President |
Other disposed transaction
F
|
Common Stock | 1,892 | $573.74 | $1,085,516 | 214,635 |
| 2025-02-26 | Rosa David J. | President |
Exercise / conversion
M
|
Common Stock | 3,816 | $0.00 | $0 | 216,527 |
| 2025-02-26 | Rosa David J. | President |
Other disposed transaction
F
|
Common Stock | 848 | $573.74 | $486,532 | 212,711 |
| 2025-02-26 | Rosa David J. | President |
Exercise / conversion
M
|
Common Stock | 1,710 | $0.00 | $0 | 213,559 |
| 2025-02-12 | LOEB GARY | EVP & Chief Legal and Complian |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,300 | $0.00 | $0 | 7,850 |
| 2025-02-12 | LOEB GARY | EVP & Chief Legal and Complian |
Open-market sell
S
|
Common Stock | 1,300 | $583.79 | $758,927 | 3,176 |
| 2025-02-12 | LOEB GARY | EVP & Chief Legal and Complian |
Exercise / conversion
M
|
Common Stock | 1,300 | $186.55 | $242,515 | 4,476 |
| 2025-02-11 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 408 | $589.75 | $240,618 | 353 |
| 2025-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 838 | $0.00 | $0 | 1,676 |
| 2025-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 430 | $582.98 | $250,681 | 761 |
| 2025-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 838 | $0.00 | $0 | 1,191 |
| 2025-01-29 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 94 | $0.00 | $0 | 1,222 |
| 2025-01-29 | Samath Jamie | EVP & CFO & Enterprise Technol |
Open-market sell
S
|
Common Stock | 94 | $571.11 | $53,684 | 2,630 |
| 2025-01-29 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M
|
Common Stock | 94 | $208.90 | $19,637 | 2,724 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 135 | $0.00 | $0 | 3,366 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 1,222 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 105 | $0.00 | $0 | 54 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 134 | $0.00 | $0 | 3,367 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 94 | $0.00 | $0 | 1,316 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Open-market sell
S
|
Common Stock | 6,127 | $575.00 | $3,523,025 | 2,630 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Open-market sell
S
|
Common Stock | 94 | $566.60 | $53,260 | 8,757 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M
|
Common Stock | 94 | $208.90 | $19,637 | 8,851 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Open-market sell
S
|
Common Stock | 134 | $566.60 | $75,924 | 8,757 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M
|
Common Stock | 134 | $229.39 | $30,738 | 8,891 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Open-market sell
S
|
Common Stock | 135 | $566.60 | $76,491 | 8,757 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M
|
Common Stock | 135 | $304.67 | $41,130 | 8,892 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Open-market sell
S
|
Common Stock | 105 | $566.60 | $59,493 | 8,757 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M
|
Common Stock | 105 | $245.60 | $25,788 | 8,862 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Open-market sell
S
|
Common Stock | 188 | $566.60 | $106,521 | 8,757 |
| 2025-01-28 | Samath Jamie | EVP & CFO & Enterprise Technol |
Exercise / conversion
M
|
Common Stock | 188 | $290.33 | $54,582 | 8,945 |
| 2024-12-10 | Samath Jamie | CFO and Head of Business Techn |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 135 | $0.00 | $0 | 3,501 |
| 2024-12-10 | Samath Jamie | CFO and Head of Business Techn |
Open-market sell
S
|
Common Stock | 135 | $540.15 | $72,921 | 8,757 |
| 2024-12-10 | Samath Jamie | CFO and Head of Business Techn |
Exercise / conversion
M
|
Common Stock | 135 | $229.39 | $30,968 | 8,892 |
| 2024-11-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 2,820 |
| 2024-11-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $539.00 | $101,332 | 5,506 |
| 2024-11-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,694 |
| 2024-11-26 | Samath Jamie | CFO and Head of Business Techn |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 54 | $0.00 | $0 | 159 |
| 2024-11-26 | Samath Jamie | CFO and Head of Business Techn |
Open-market sell
S
|
Common Stock | 54 | $542.06 | $29,271 | 8,757 |
| 2024-11-26 | Samath Jamie | CFO and Head of Business Techn |
Exercise / conversion
M
|
Common Stock | 54 | $245.60 | $13,262 | 8,811 |
| 2024-11-22 | Rosa David J. | President |
Equity grant / award
G
|
Common Stock | 915 | $0.00 | $0 | 211,080 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,199 | $0.00 | $0 | 2,829 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 4,010 | $0.00 | $0 | 2,005 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 5,000 | $0.00 | $0 | 0 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,257 | $0.00 | $0 | 0 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 4,010 | $535.96 | $2,149,187 | 298 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 4,010 | $208.90 | $837,689 | 4,308 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 2,199 | $535.96 | $1,178,569 | 298 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 2,199 | $229.39 | $504,429 | 2,497 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 5,000 | $535.96 | $2,679,784 | 298 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 5,000 | $182.83 | $914,166 | 5,298 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 2,257 | $535.96 | $1,209,655 | 298 |
| 2024-11-12 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 2,257 | $177.99 | $401,716 | 2,555 |
| 2024-11-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 120 | $0.00 | $0 | 3,232 |
| 2024-11-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 119 | $0.00 | $0 | 3,233 |
| 2024-11-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 119 | $539.89 | $64,247 | 5,506 |
| 2024-11-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 119 | $229.39 | $27,297 | 5,625 |
| 2024-11-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 120 | $539.89 | $64,787 | 5,506 |
| 2024-11-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 120 | $304.67 | $36,560 | 5,626 |
| 2024-11-11 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 134 | $0.00 | $0 | 3,636 |
| 2024-11-11 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 135 | $0.00 | $0 | 3,636 |
| 2024-11-11 | Samath Jamie | See Remarks |
Open-market sell
S
|
Common Stock | 269 | $539.89 | $145,230 | 8,757 |
| 2024-11-11 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 135 | $229.39 | $30,968 | 9,026 |
| 2024-11-11 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 134 | $304.67 | $40,826 | 8,891 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,693 | $0.00 | $0 | 3,771 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,694 | $0.00 | $0 | 3,770 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 432 | $0.00 | $0 | 0 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,449 | $0.00 | $0 | 0 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,521 | $0.00 | $0 | 0 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,515 | $0.00 | $0 | 0 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,352 | $0.00 | $0 | 213 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 3,007 | $0.00 | $0 | 1,504 |
| 2024-11-08 | Samath Jamie | See Remarks |
Open-market sell
S
|
Common Stock | 22,903 | $525.00 | $12,024,075 | 8,757 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 2,693 | $229.39 | $617,747 | 28,653 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 2,694 | $304.67 | $820,781 | 25,960 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 432 | $139.52 | $60,273 | 23,266 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 1,449 | $182.83 | $264,925 | 22,402 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 1,521 | $177.99 | $270,718 | 19,504 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 1,515 | $242.34 | $367,140 | 17,983 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 2,352 | $245.60 | $577,651 | 16,468 |
| 2024-11-08 | Samath Jamie | See Remarks |
Exercise / conversion
M
|
Common Stock | 3,007 | $208.90 | $628,162 | 31,660 |
| 2024-11-05 | Rosa David J. | President |
Equity grant / award
G
|
Common Stock | 1,980 | $0.00 | $0 | 211,995 |
| 2024-10-30 | GUTHART GARY S | CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 25,200 | $0.00 | $0 | 0 |
| 2024-10-30 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 3,720 | $510.75 | $1,900,003 | 19,920 |
| 2024-10-30 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 18,151 | $511.63 | $9,286,674 | 24,219 |
| 2024-10-30 | GUTHART GARY S | CEO |
Exercise / conversion
M
|
Common Stock | 25,200 | $59.23 | $1,492,541 | 42,370 |
| 2024-10-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 3,008 |
| 2024-10-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $506.52 | $95,226 | 5,506 |
| 2024-10-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,694 |
| 2024-10-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 3,008 |
| 2024-10-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 198 | $0.00 | $0 | 795 |
| 2024-10-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 198 | $513.66 | $101,705 | 5,506 |
| 2024-10-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 198 | $245.60 | $48,629 | 5,704 |
| 2024-10-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $513.66 | $96,568 | 5,506 |
| 2024-10-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $290.33 | $54,582 | 5,694 |
| 2024-10-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 198 | $0.00 | $0 | 993 |
| 2024-10-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 120 | $0.00 | $0 | 3,352 |
| 2024-10-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 3,196 |
| 2024-10-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 120 | $514.00 | $61,680 | 5,506 |
| 2024-10-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 120 | $229.39 | $27,527 | 5,626 |
| 2024-10-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 198 | $514.00 | $101,772 | 5,506 |
| 2024-10-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 198 | $245.60 | $48,629 | 5,704 |
| 2024-10-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $514.00 | $96,632 | 5,506 |
| 2024-10-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,694 |
| 2024-10-24 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 22 | $510.79 | $11,237 | 229 |
| 2024-10-23 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 22 | $513.89 | $11,306 | 251 |
| 2024-10-22 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,106 | $0.00 | $0 | 0 |
| 2024-10-22 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 22 | $515.00 | $11,330 | 273 |
| 2024-10-22 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 2,106 | $515.00 | $1,084,590 | 295 |
| 2024-10-22 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Exercise / conversion
M
|
Common Stock | 2,106 | $77.00 | $162,160 | 2,401 |
| 2024-10-10 | LOEB GARY | General Counsel |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,613 | $0.00 | $0 | 5,224 |
| 2024-10-10 | LOEB GARY | General Counsel |
Other disposed transaction
F
|
Common Stock | 1,178 | $490.38 | $577,668 | 3,030 |
| 2024-10-10 | LOEB GARY | General Counsel |
Exercise / conversion
M
|
Common Stock | 2,613 | $0.00 | $0 | 4,208 |
| 2024-09-13 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 450 | $490.28 | $220,626 | 821 |
| 2024-09-12 | Brosius Mark | See Remarks |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option | 2,115 | $0.00 | $0 | 0 |
| 2024-09-12 | Brosius Mark | See Remarks |
Open-market sell
S
|
Common Stock | 2,115 | $491.91 | $1,040,390 | 295 |
| 2024-09-12 | Brosius Mark | See Remarks |
Exercise / conversion
M
|
Common Stock | 2,115 | $59.46 | $125,763 | 2,410 |
| 2024-09-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 119 | $0.00 | $0 | 3,472 |
| 2024-09-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 119 | $477.50 | $56,822 | 5,506 |
| 2024-09-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 119 | $229.39 | $27,297 | 5,625 |
| 2024-09-09 | LOEB GARY | General Counsel |
Open-market sell
S
|
Common Stock | 300 | $475.00 | $142,500 | 1,595 |
| 2024-08-31 | MOHR MARSHALL | Executive VP Global Business S |
Other disposed transaction
F
|
Common Stock | 1,698 | $492.63 | $836,486 | 1,650 |
| 2024-08-31 | MOHR MARSHALL | Executive VP Global Business S |
Equity grant / award
A
|
Common Stock | 3,348 | $0.00 | $0 | 3,348 |
| 2024-08-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 3,384 |
| 2024-08-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $482.21 | $90,655 | 5,506 |
| 2024-08-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,694 |
| 2024-08-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 3,384 |
| 2024-08-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $482.93 | $90,791 | 5,506 |
| 2024-08-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $290.33 | $54,582 | 5,694 |
| 2024-08-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 198 | $0.00 | $0 | 1,191 |
| 2024-08-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 198 | $486.88 | $96,402 | 5,506 |
| 2024-08-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 198 | $245.60 | $48,629 | 5,704 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,336 | $0.00 | $0 | 0 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,414 | $0.00 | $0 | 1,336 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,625 | $0.00 | $0 | 0 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 3,750 | $0.00 | $0 | 0 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 422 | $0.00 | $0 | 0 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 5,203 | $0.00 | $0 | 422 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 468 | $0.00 | $0 | 0 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 456 | $0.00 | $0 | 0 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 459 | $0.00 | $0 | 0 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 6,829 | $486.85 | $3,324,684 | 3,001 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 6,828 | $486.86 | $3,324,290 | 9,830 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 459 | $486.84 | $223,458 | 23,486 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 459 | $59.46 | $27,293 | 23,945 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 456 | $486.84 | $221,998 | 23,486 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 456 | $77.00 | $35,112 | 23,942 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 468 | $486.84 | $227,840 | 23,486 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 468 | $79.64 | $37,270 | 23,954 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 422 | $486.81 | $205,435 | 23,486 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 422 | $109.49 | $46,203 | 23,908 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 5,203 | $486.84 | $2,533,015 | 23,486 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 5,203 | $109.49 | $569,654 | 28,689 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 3,750 | $486.81 | $1,825,544 | 23,486 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 3,750 | $139.52 | $523,200 | 27,236 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 1,336 | $486.85 | $650,429 | 23,486 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 1,336 | $174.26 | $232,807 | 24,822 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 2,414 | $486.81 | $1,175,163 | 23,486 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 2,414 | $174.26 | $420,656 | 25,900 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Open-market sell
S
|
Common Stock | 2,625 | $486.85 | $1,277,977 | 23,486 |
| 2024-08-23 | Charlton Henry L | SVP & Chief Commercial and Mkt |
Exercise / conversion
M
|
Common Stock | 2,625 | $182.83 | $479,937 | 26,111 |
| 2024-08-12 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 120 | $0.00 | $0 | 3,591 |
| 2024-08-12 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 120 | $464.76 | $55,771 | 5,506 |
| 2024-08-12 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 120 | $229.39 | $27,527 | 5,626 |
| 2024-08-01 | Johnson Amal M | — |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,943 | $0.00 | $0 | 0 |
| 2024-08-01 | Johnson Amal M | — |
Open-market sell
S
|
Common Stock | 2,943 | $443.30 | $1,304,632 | 12,275 |
| 2024-08-01 | Johnson Amal M | — |
Exercise / conversion
M
|
Common Stock | 2,943 | $71.32 | $209,904 | 15,218 |
| 2024-07-30 | GUTHART GARY S | CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 25,200 | $0.00 | $0 | 0 |
| 2024-07-30 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 3,720 | $445.12 | $1,655,833 | 23,640 |
| 2024-07-30 | GUTHART GARY S | CEO |
Equity grant / award
G
|
Common Stock | 12,500 | $0.00 | $0 | 1,191,144 |
| 2024-07-30 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 23,388 | $443.07 | $10,362,516 | 17,170 |
| 2024-07-30 | GUTHART GARY S | CEO |
Exercise / conversion
M
|
Common Stock | 25,200 | $57.11 | $1,439,200 | 40,558 |
| 2024-07-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 3,572 |
| 2024-07-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $446.60 | $83,961 | 5,506 |
| 2024-07-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,694 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 3,760 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 399 | $0.00 | $0 | 1,389 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 120 | $0.00 | $0 | 3,711 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 187 | $0.00 | $0 | 3,760 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 187 | $438.60 | $82,018 | 5,506 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 187 | $208.90 | $39,064 | 5,693 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 120 | $438.60 | $52,632 | 5,506 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 120 | $229.39 | $27,527 | 5,626 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 399 | $438.60 | $175,001 | 5,506 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 399 | $245.60 | $97,994 | 5,905 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $438.60 | $82,457 | 5,506 |
| 2024-07-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $290.33 | $54,582 | 5,694 |
| 2024-07-23 | BARRATT CRAIG H | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,400 | $0.00 | $0 | 0 |
| 2024-07-23 | BARRATT CRAIG H | Dir |
Open-market sell
S
|
Common Stock | 1,400 | $458.13 | $641,382 | 0 |
| 2024-07-23 | BARRATT CRAIG H | Dir |
Exercise / conversion
M
|
Common Stock | 1,400 | $56.97 | $79,764 | 1,400 |
| 2024-06-12 | BARRATT CRAIG H | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,400 | $0.00 | $0 | 1,400 |
| 2024-06-12 | BARRATT CRAIG H | Dir |
Open-market sell
S
|
Common Stock | 1,400 | $421.06 | $589,484 | 0 |
| 2024-06-12 | BARRATT CRAIG H | Dir |
Exercise / conversion
M
|
Common Stock | 1,400 | $56.97 | $79,764 | 1,400 |
| 2024-06-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 119 | $0.00 | $0 | 3,831 |
| 2024-06-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 120 | $0.00 | $0 | 3,831 |
| 2024-06-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 120 | $416.60 | $49,992 | 5,506 |
| 2024-06-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 120 | $229.39 | $27,527 | 5,626 |
| 2024-06-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 119 | $416.60 | $49,575 | 5,506 |
| 2024-06-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 119 | $304.67 | $36,256 | 5,625 |
| 2024-06-05 | BARRATT CRAIG H | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,400 | $0.00 | $0 | 2,800 |
| 2024-06-05 | BARRATT CRAIG H | Dir |
Open-market sell
S
|
Common Stock | 1,400 | $411.00 | $575,400 | 0 |
| 2024-06-05 | BARRATT CRAIG H | Dir |
Exercise / conversion
M
|
Common Stock | 1,400 | $56.97 | $79,764 | 1,400 |
| 2024-06-03 | BARRATT CRAIG H | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,096 | $0.00 | $0 | 4,200 |
| 2024-06-03 | BARRATT CRAIG H | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,400 | $0.00 | $0 | 5,296 |
| 2024-06-03 | BARRATT CRAIG H | Dir |
Open-market sell
S
|
Common Stock | 1,096 | $402.89 | $441,567 | 0 |
| 2024-06-03 | BARRATT CRAIG H | Dir |
Exercise / conversion
M
|
Common Stock | 1,096 | $56.97 | $62,444 | 1,096 |
| 2024-06-03 | BARRATT CRAIG H | Dir |
Open-market sell
S
|
Common Stock | 1,400 | $402.89 | $564,046 | 0 |
| 2024-06-03 | BARRATT CRAIG H | Dir |
Exercise / conversion
M
|
Common Stock | 1,400 | $56.97 | $79,764 | 1,400 |
| 2024-05-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 3,947 |
| 2024-05-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $396.59 | $74,559 | 5,506 |
| 2024-05-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,694 |
| 2024-05-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 3,948 |
| 2024-05-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 198 | $0.00 | $0 | 1,788 |
| 2024-05-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 198 | $404.41 | $80,073 | 5,506 |
| 2024-05-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 198 | $245.60 | $48,629 | 5,704 |
| 2024-05-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $404.41 | $76,029 | 5,506 |
| 2024-05-28 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $290.33 | $54,582 | 5,694 |
| 2024-05-17 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 63 | $396.19 | $24,960 | 295 |
| 2024-05-17 | Rosa David J. | President |
Equity grant / award
G
|
Common Stock | 2,507 | $0.00 | $0 | 215,285 |
| 2024-05-16 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 175 | $398.28 | $69,699 | 358 |
| 2024-05-15 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 175 | $387.22 | $67,764 | 533 |
| 2024-05-14 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 175 | $380.85 | $66,649 | 708 |
| 2024-05-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 90 | $0.00 | $0 | 0 |
| 2024-05-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 194 | $389.16 | $75,497 | 5,506 |
| 2024-05-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 90 | $389.16 | $35,024 | 5,700 |
| 2024-05-13 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 90 | $179.70 | $16,173 | 5,790 |
| 2024-05-13 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 175 | $389.16 | $68,103 | 883 |
| 2024-05-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 360 | $0.00 | $0 | 0 |
| 2024-05-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Other disposed transaction
F
|
Common Stock | 167 | $386.70 | $64,579 | 5,700 |
| 2024-05-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 360 | $0.00 | $0 | 5,867 |
| 2024-05-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 120 | $0.00 | $0 | 3,950 |
| 2024-05-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 119 | $0.00 | $0 | 3,951 |
| 2024-05-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 119 | $385.55 | $45,880 | 5,507 |
| 2024-05-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 119 | $229.39 | $27,297 | 5,626 |
| 2024-05-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 120 | $385.55 | $46,266 | 5,507 |
| 2024-05-10 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 120 | $304.67 | $36,560 | 5,627 |
| 2024-05-03 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,709 | $0.00 | $0 | 0 |
| 2024-05-03 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 1,709 | $380.00 | $649,420 | 16,051 |
| 2024-05-03 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 1,709 | $295.92 | $505,727 | 17,760 |
| 2024-04-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 4,136 |
| 2024-04-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $375.39 | $70,573 | 5,507 |
| 2024-04-29 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,695 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 396 | $0.00 | $0 | 1,986 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 120 | $0.00 | $0 | 4,070 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 188 | $0.00 | $0 | 4,324 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 90 | $0.00 | $0 | 90 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 120 | $368.10 | $44,172 | 5,507 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 120 | $229.39 | $27,527 | 5,627 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 90 | $368.10 | $33,129 | 5,507 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 90 | $179.70 | $16,173 | 5,597 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 396 | $368.10 | $145,768 | 5,507 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 396 | $245.60 | $97,258 | 5,903 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 188 | $368.10 | $69,203 | 5,507 |
| 2024-04-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 188 | $208.90 | $39,273 | 5,695 |
| 2024-04-25 | RUBASH MARK J | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 739 | $0.00 | $0 | 739 |
| 2024-04-25 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 569 | $0.00 | $0 | 0 |
| 2024-04-25 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 569 | $0.00 | $0 | 16,051 |
| 2024-04-23 | LEVY ALAN J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,000 | $0.00 | $0 | 916 |
| 2024-04-23 | LEVY ALAN J | Dir |
Open-market sell
S
|
Common Stock | 2,000 | $370.70 | $741,398 | 25,319 |
| 2024-04-23 | LEVY ALAN J | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $154.24 | $308,473 | 27,319 |
| 2024-03-15 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 612 | $0.00 | $0 | 0 |
| 2024-03-15 | Widman Fredrik | VP Corporate Controller |
Open-market sell
S
|
Common Stock | 612 | $397.07 | $243,007 | 110 |
| 2024-03-15 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M
|
Common Stock | 612 | $59.23 | $36,247 | 722 |
| 2024-03-15 | Widman Fredrik | VP Corporate Controller |
Open-market sell
S
|
Common Stock | 3,817 | $397.07 | $1,515,616 | 110 |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 119 | $0.00 | $0 | 4,190 |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 120 | $0.00 | $0 | 4,190 |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 90 | $0.00 | $0 | 180 |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 120 | $390.16 | $46,819 | 5,507 |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 120 | $229.39 | $27,527 | 5,627 |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 119 | $390.16 | $46,429 | 5,507 |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 119 | $304.67 | $36,256 | 5,626 |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 90 | $390.16 | $35,114 | 5,507 |
| 2024-03-11 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 90 | $179.70 | $16,173 | 5,597 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,149 | $0.00 | $0 | 2,382 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,437 | $0.00 | $0 | 4,309 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,504 | $0.00 | $0 | 4,512 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 993 | $0.00 | $0 | 2,382 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,436 | $0.00 | $0 | 4,310 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 940 | $0.00 | $0 | 4,511 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 363 | $0.00 | $0 | 270 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 453 | $0.00 | $0 | 0 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 2,749 | $393.83 | $1,082,641 | 5,507 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 2,819 | $393.79 | $1,110,106 | 8,256 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 940 | $393.82 | $370,187 | 11,075 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 940 | $208.90 | $196,366 | 12,015 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 1,436 | $393.82 | $565,520 | 11,075 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 1,436 | $229.39 | $329,404 | 12,511 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 1,437 | $393.80 | $565,893 | 11,075 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 1,437 | $304.67 | $437,811 | 12,512 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 363 | $393.80 | $142,948 | 11,075 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 363 | $179.70 | $65,231 | 11,438 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 453 | $393.80 | $178,390 | 11,075 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 453 | $177.99 | $80,628 | 11,528 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 993 | $393.80 | $391,046 | 11,075 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 993 | $245.60 | $243,881 | 12,068 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 7,149 | $393.77 | $2,815,097 | 11,075 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 7,149 | $347.42 | $2,483,682 | 18,224 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 1,504 | $393.81 | $592,287 | 11,075 |
| 2024-03-08 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 1,504 | $290.33 | $436,656 | 12,579 |
| 2024-03-07 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 196 | $393.30 | $77,087 | 1,450 |
| 2024-03-06 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 196 | $386.76 | $75,805 | 1,646 |
| 2024-03-05 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 196 | $400.00 | $78,400 | 1,842 |
| 2024-03-01 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,605 | $383.48 | $615,485 | 298 |
| 2024-02-29 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,003 | $0.00 | $0 | 2,004 |
| 2024-02-29 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,253 | $0.00 | $0 | 0 |
| 2024-02-29 | MOHR MARSHALL | Executive VP Global Business S |
Other disposed transaction
F
|
Common Stock | 509 | $386.59 | $196,774 | 49,502 |
| 2024-02-29 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 1,003 | $0.00 | $0 | 50,011 |
| 2024-02-29 | MOHR MARSHALL | Executive VP Global Business S |
Other disposed transaction
F
|
Common Stock | 1,142 | $386.59 | $441,486 | 49,008 |
| 2024-02-29 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 2,253 | $0.00 | $0 | 50,150 |
| 2024-02-29 | GUTHART GARY S | CEO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,506 | $0.00 | $0 | 5,012 |
| 2024-02-29 | GUTHART GARY S | CEO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 3,864 | $0.00 | $0 | 0 |
| 2024-02-29 | GUTHART GARY S | CEO |
Other disposed transaction
F
|
Common Stock | 1,271 | $386.59 | $491,356 | 15,358 |
| 2024-02-29 | GUTHART GARY S | CEO |
Exercise / conversion
M
|
Common Stock | 2,506 | $0.00 | $0 | 16,629 |
| 2024-02-29 | GUTHART GARY S | CEO |
Other disposed transaction
F
|
Common Stock | 1,959 | $386.59 | $757,330 | 14,123 |
| 2024-02-29 | GUTHART GARY S | CEO |
Exercise / conversion
M
|
Common Stock | 3,864 | $0.00 | $0 | 16,082 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 13,530 | $0.00 | $0 | 0 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,500 | $0.00 | $0 | 0 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 12,750 | $0.00 | $0 | 0 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 22,500 | $0.00 | $0 | 0 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 11,250 | $0.00 | $0 | 0 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Open-market sell
S
|
Common Stock | 6,860 | $385.08 | $2,641,659 | 47,897 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 11,250 | $77.00 | $866,238 | 54,757 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Open-market sell
S
|
Common Stock | 13,750 | $385.08 | $5,294,842 | 43,507 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Open-market sell
S
|
Common Stock | 14,620 | $385.09 | $5,630,044 | 34,757 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 22,500 | $79.64 | $1,791,850 | 57,257 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Open-market sell
S
|
Common Stock | 12,750 | $385.08 | $4,909,776 | 26,877 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 12,750 | $139.52 | $1,778,880 | 39,627 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Open-market sell
S
|
Common Stock | 10,500 | $385.08 | $4,043,345 | 47,897 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 10,500 | $182.83 | $1,919,750 | 58,397 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Open-market sell
S
|
Common Stock | 13,530 | $385.08 | $5,210,139 | 26,877 |
| 2024-02-28 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 13,530 | $177.99 | $2,408,160 | 40,407 |
| 2024-02-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Equity grant / award
A · derivative
|
Restricted Stock Units - 2-26-2024 | 6,105 | $0.00 | $0 | 6,105 |
| 2024-02-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,587 | $0.00 | $0 | 1,587 |
| 2024-02-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Other disposed transaction
F
|
Common Stock | 498 | $389.77 | $194,105 | 9,099 |
| 2024-02-26 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 1,587 | $0.00 | $0 | 9,597 |
| 2024-02-16 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 32 | $378.29 | $12,105 | 709 |
| 2024-02-15 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 30 | $382.03 | $11,461 | 741 |
| 2024-02-15 | Leonard Keith R | Dir |
Equity grant / award
G
|
Common Stock | 2,547 | $0.00 | $0 | 1,037 |
| 2024-02-14 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 30 | $380.09 | $11,403 | 771 |
| 2024-02-13 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 30 | $375.50 | $11,265 | 801 |
| 2024-02-12 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 30 | $386.09 | $11,583 | 831 |
| 2024-02-12 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 481 | $386.09 | $185,709 | 298 |
| 2024-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 838 | $0.00 | $0 | 2,514 |
| 2024-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 357 | $388.22 | $138,595 | 779 |
| 2024-02-10 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 838 | $0.00 | $0 | 1,136 |
| 2024-02-07 | Rosa David J. | President |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 22,050 | $0.00 | $0 | 0 |
| 2024-02-07 | Rosa David J. | President |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 28,125 | $0.00 | $0 | 0 |
| 2024-02-07 | Rosa David J. | President |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 40,500 | $0.00 | $0 | 0 |
| 2024-02-07 | Rosa David J. | President |
Open-market sell
S
|
Common Stock | 15,700 | $389.29 | $6,111,784 | 214,389 |
| 2024-02-07 | Rosa David J. | President |
Open-market sell
S
|
Common Stock | 23,120 | $389.28 | $9,000,195 | 201,964 |
| 2024-02-07 | Rosa David J. | President |
Exercise / conversion
M
|
Common Stock | 40,500 | $49.09 | $1,988,100 | 225,084 |
| 2024-02-07 | Rosa David J. | President |
Open-market sell
S
|
Common Stock | 16,150 | $389.23 | $6,286,026 | 184,584 |
| 2024-02-07 | Rosa David J. | President |
Exercise / conversion
M
|
Common Stock | 28,125 | $49.34 | $1,387,780 | 230,089 |
| 2024-02-07 | Rosa David J. | President |
Open-market sell
S
|
Common Stock | 12,840 | $389.30 | $4,998,665 | 172,609 |
| 2024-02-07 | Rosa David J. | President |
Open-market sell
S
|
Common Stock | 12,900 | $389.29 | $5,021,798 | 163,399 |
| 2024-02-07 | Rosa David J. | President |
Exercise / conversion
M
|
Common Stock | 22,050 | $57.11 | $1,259,300 | 185,449 |
| 2024-02-01 | Brosius Mark | SVP & Chief Mfg and Supply Cha |
Open-market sell
S
|
Common Stock | 39 | $378.41 | $14,758 | 448 |
| 2024-01-29 | GUTHART GARY S | CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 33,750 | $0.00 | $0 | 0 |
| 2024-01-29 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 2,480 | $374.41 | $928,537 | 27,360 |
| 2024-01-29 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 24,325 | $376.06 | $9,147,669 | 9,425 |
| 2024-01-29 | GUTHART GARY S | CEO |
Exercise / conversion
M
|
Common Stock | 33,750 | $51.02 | $1,721,776 | 33,750 |
| 2024-01-26 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,500 | $0.00 | $0 | 7,500 |
| 2024-01-26 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,818 | $0.00 | $0 | 7,893 |
| 2024-01-26 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,500 | $370.15 | $555,222 | 189 |
| 2024-01-26 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,500 | $182.83 | $274,250 | 1,689 |
| 2024-01-26 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 2,818 | $370.15 | $1,043,076 | 189 |
| 2024-01-26 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 2,818 | $177.99 | $501,567 | 3,007 |
| 2023-12-13 | Rosa David J. | President |
Equity grant / award
G
|
Common Stock | 1,572 | $0.00 | $0 | 154,140 |
| 2023-11-16 | Johnson Amal M | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 9,567 | $0.00 | $0 | 0 |
| 2023-11-16 | Johnson Amal M | Dir |
Open-market sell
S
|
Common Stock | 9,567 | $300.00 | $2,870,100 | 11,706 |
| 2023-11-16 | Johnson Amal M | Dir |
Exercise / conversion
M
|
Common Stock | 9,567 | $41.26 | $394,713 | 21,273 |
| 2023-11-14 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 597 | $0.00 | $0 | 3,375 |
| 2023-11-14 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 270 | $0.00 | $0 | 453 |
| 2023-11-14 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 270 | $290.00 | $78,300 | 7,259 |
| 2023-11-14 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 270 | $242.34 | $65,431 | 7,529 |
| 2023-11-14 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 597 | $290.00 | $173,130 | 7,259 |
| 2023-11-14 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 597 | $245.60 | $146,623 | 7,856 |
| 2023-11-10 | Kolli Sreelakshmi | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 240 | $0.00 | $0 | 240 |
| 2023-11-10 | Kolli Sreelakshmi | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 722 | $0.00 | $0 | 722 |
| 2023-10-26 | GUTHART GARY S | CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 33,750 | $0.00 | $0 | 0 |
| 2023-10-26 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 27,385 | $260.11 | $7,123,030 | 23,551 |
| 2023-10-26 | GUTHART GARY S | CEO |
Exercise / conversion
M
|
Common Stock | 33,750 | $49.34 | $1,665,336 | 50,936 |
| 2023-10-24 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 2,480 | $271.93 | $674,386 | 29,840 |
| 2023-10-10 | LOEB GARY | General Counsel |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,613 | $0.00 | $0 | 7,837 |
| 2023-10-10 | LOEB GARY | General Counsel |
Other disposed transaction
F
|
Common Stock | 904 | $297.83 | $269,238 | 1,709 |
| 2023-10-10 | LOEB GARY | General Counsel |
Exercise / conversion
M
|
Common Stock | 2,613 | $0.00 | $0 | 2,613 |
| 2023-09-14 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 500 | $305.68 | $152,840 | 702 |
| 2023-08-10 | MOHR MARSHALL | Executive VP Global Business S |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 2,873 | $0.00 | $0 | 2,873 |
| 2023-08-07 | LEVY ALAN J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,535 | $0.00 | $0 | 3,928 |
| 2023-08-07 | LEVY ALAN J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 465 | $0.00 | $0 | 0 |
| 2023-08-07 | LEVY ALAN J | Dir |
Open-market sell
S
|
Common Stock | 465 | $310.00 | $144,150 | 25,319 |
| 2023-08-07 | LEVY ALAN J | Dir |
Exercise / conversion
M
|
Common Stock | 465 | $71.32 | $33,165 | 25,784 |
| 2023-08-07 | LEVY ALAN J | Dir |
Open-market sell
S
|
Common Stock | 1,535 | $310.00 | $475,850 | 25,319 |
| 2023-08-07 | LEVY ALAN J | Dir |
Exercise / conversion
M
|
Common Stock | 1,535 | $90.49 | $138,909 | 26,854 |
| 2023-07-31 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 2,480 | $325.89 | $808,207 | 32,320 |
| 2023-07-28 | GUTHART GARY S | CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 67,500 | $0.00 | $0 | 0 |
| 2023-07-28 | GUTHART GARY S | CEO |
Equity grant / award
G
|
Common Stock | 16,000 | $0.00 | $0 | 1,180,093 |
| 2023-07-28 | GUTHART GARY S | CEO |
Open-market sell
S
|
Common Stock | 50,314 | $326.76 | $16,440,733 | 17,186 |
| 2023-07-28 | GUTHART GARY S | CEO |
Exercise / conversion
M
|
Common Stock | 67,500 | $42.64 | $2,877,977 | 67,500 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 594 | $0.00 | $0 | 3,972 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 273 | $0.00 | $0 | 723 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 564 | $0.00 | $0 | 6,016 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 270 | $0.00 | $0 | 906 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 270 | $322.76 | $87,145 | 7,259 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 270 | $177.99 | $48,056 | 7,529 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 273 | $322.76 | $88,113 | 7,259 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 273 | $242.34 | $66,158 | 7,532 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 594 | $322.76 | $191,719 | 7,259 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 594 | $245.60 | $145,886 | 7,853 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Open-market sell
S
|
Common Stock | 564 | $322.76 | $182,037 | 7,259 |
| 2023-07-25 | DeSantis Robert | EVP & Chief Strategy & Corp Op |
Exercise / conversion
M
|
Common Stock | 564 | $208.90 | $117,820 | 7,823 |
| 2023-06-14 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 11,250 | $0.00 | $0 | 0 |
| 2023-06-14 | MOHR MARSHALL | Executive VP Global Business S |
Open-market sell
S
|
Common Stock | 11,250 | $325.00 | $3,656,250 | 24,136 |
| 2023-06-14 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 11,250 | $59.46 | $668,950 | 35,386 |
| 2023-06-12 | Rosa David J. | President |
Equity grant / award
A · derivative
|
Restricted Stock Units | 5,433 | $0.00 | $0 | 5,433 |
| 2023-06-12 | Rosa David J. | President |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 16,297 | $0.00 | $0 | 16,297 |
| 2023-05-11 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 363 | $0.00 | $0 | 360 |
| 2023-05-11 | DeSantis Robert | EVP & Chief Product Officer |
Other disposed transaction
F
|
Common Stock | 169 | $303.47 | $51,286 | 7,259 |
| 2023-05-11 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 363 | $0.00 | $0 | 7,428 |
| 2023-05-02 | Curet Myriam | EVP & Chief Medical Officer |
Equity grant / award
G
|
Common Stock | 138 | $0.00 | $0 | 189 |
| 2023-05-01 | BARRATT CRAIG H | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,000 | $0.00 | $0 | 1,567 |
| 2023-05-01 | BARRATT CRAIG H | Dir |
Open-market sell
S
|
Common Stock | 2,000 | $306.00 | $612,000 | 0 |
| 2023-05-01 | BARRATT CRAIG H | Dir |
Exercise / conversion
M
|
Common Stock | 2,000 | $41.26 | $82,516 | 2,000 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,671 | $0.00 | $0 | 0 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,448 | $0.00 | $0 | 0 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 707 | $0.00 | $0 | 0 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 688 | $0.00 | $0 | 0 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 895 | $0.00 | $0 | 0 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,391 | $0.00 | $0 | 0 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 523 | $0.00 | $0 | 0 |
| 2023-04-28 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 523 | $300.00 | $156,900 | 15,482 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 523 | $71.32 | $37,302 | 16,005 |
| 2023-04-28 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 1,391 | $300.00 | $417,300 | 15,482 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 1,391 | $90.49 | $125,878 | 16,873 |
| 2023-04-28 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 895 | $300.00 | $268,500 | 15,482 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 895 | $154.24 | $138,042 | 16,377 |
| 2023-04-28 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 707 | $300.00 | $212,100 | 15,482 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 707 | $172.59 | $122,023 | 16,189 |
| 2023-04-28 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 688 | $300.00 | $206,400 | 15,482 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 688 | $171.07 | $117,698 | 16,170 |
| 2023-04-28 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 1,671 | $300.00 | $501,300 | 15,482 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 1,671 | $286.55 | $478,831 | 17,153 |
| 2023-04-28 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 1,448 | $300.00 | $434,400 | 15,482 |
| 2023-04-28 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 1,448 | $243.26 | $352,240 | 16,930 |
| 2023-04-27 | RUBASH MARK J | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 569 | $0.00 | $0 | 569 |
| 2023-04-27 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 482 | $0.00 | $0 | 0 |
| 2023-04-27 | RUBASH MARK J | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 1,709 | $0.00 | $0 | 1,709 |
| 2023-04-27 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 482 | $0.00 | $0 | 15,482 |
| 2023-04-24 | Rosa David J. | EVP Chief Strategy & Growth Of |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 54,000 | $0.00 | $0 | 0 |
| 2023-04-24 | Rosa David J. | EVP Chief Strategy & Growth Of |
Open-market sell
S
|
Common Stock | 40,764 | $299.20 | $12,196,446 | 155,712 |
| 2023-04-24 | Rosa David J. | EVP Chief Strategy & Growth Of |
Exercise / conversion
M
|
Common Stock | 54,000 | $42.64 | $2,302,382 | 196,476 |
| 2023-04-21 | Rosa David J. | EVP Chief Strategy & Growth Of |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 54,000 | $0.00 | $0 | 54,000 |
| 2023-04-21 | Rosa David J. | EVP Chief Strategy & Growth Of |
Open-market sell
S
|
Common Stock | 40,800 | $297.92 | $12,155,173 | 142,476 |
| 2023-04-21 | Rosa David J. | EVP Chief Strategy & Growth Of |
Exercise / conversion
M
|
Common Stock | 54,000 | $42.64 | $2,302,382 | 183,276 |
| 2023-03-01 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,253 | $228.47 | $286,273 | 1,950 |
| 2023-02-28 | Curet Myriam | EVP & Chief Medical Officer |
Equity grant / award
A · derivative
|
Restricted Stock Units | 3,352 | $0.00 | $0 | 3,352 |
| 2023-02-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,003 | $0.00 | $0 | 3,007 |
| 2023-02-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,256 | $0.00 | $0 | 2,253 |
| 2023-02-28 | Curet Myriam | EVP & Chief Medical Officer |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 5,028 | $0.00 | $0 | 5,028 |
| 2023-02-28 | Curet Myriam | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 498 | $229.39 | $114,236 | 3,203 |
| 2023-02-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,003 | $0.00 | $0 | 3,701 |
| 2023-02-28 | Curet Myriam | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 1,003 | $229.39 | $230,078 | 2,698 |
| 2023-02-28 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 2,256 | $0.00 | $0 | 3,701 |
| 2023-02-26 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 609 | $0.00 | $0 | 1,215 |
| 2023-02-26 | Widman Fredrik | VP Corporate Controller |
Other disposed transaction
F
|
Common Stock | 212 | $231.05 | $48,983 | 2,002 |
| 2023-02-26 | Widman Fredrik | VP Corporate Controller |
Exercise / conversion
M
|
Common Stock | 609 | $0.00 | $0 | 2,214 |
| 2023-02-16 | Widman Fredrik | VP Corporate Controller |
Open-market sell
S
|
Common Stock | 116 | $240.77 | $27,929 | 1,605 |
| 2023-02-15 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,749 | $0.00 | $0 | 0 |
| 2023-02-15 | MOHR MARSHALL | Executive VP Global Business S |
Other disposed transaction
F
|
Common Stock | 868 | $244.77 | $212,460 | 21,632 |
| 2023-02-15 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 1,749 | $0.00 | $0 | 22,500 |
| 2023-02-13 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 54,000 | $0.00 | $0 | 0 |
| 2023-02-13 | MOHR MARSHALL | Executive VP Global Business S |
Open-market sell
S
|
Common Stock | 33,249 | $245.61 | $8,166,377 | 20,751 |
| 2023-02-13 | MOHR MARSHALL | Executive VP Global Business S |
Exercise / conversion
M
|
Common Stock | 54,000 | $63.25 | $3,415,262 | 54,000 |
| 2023-02-10 | DiMartino Michele | See Remarks |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 987 | $0.00 | $0 | 2,960 |
| 2023-02-10 | DiMartino Michele | See Remarks |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,504 | $0.00 | $0 | 0 |
| 2023-02-10 | DiMartino Michele | See Remarks |
Other disposed transaction
F
|
Common Stock | 298 | $245.27 | $73,090 | 2,112 |
| 2023-02-10 | DiMartino Michele | See Remarks |
Exercise / conversion
M
|
Common Stock | 987 | — | — | 2,410 |
| 2023-02-10 | DiMartino Michele | See Remarks |
Other disposed transaction
F
|
Common Stock | 478 | $245.27 | $117,239 | 1,423 |
| 2023-02-10 | DiMartino Michele | See Remarks |
Exercise / conversion
M
|
Common Stock | 1,504 | — | — | 1,901 |
| 2023-02-06 | Rosa David J. | EVP Chief Strategy & Growth Of |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 54,000 | $0.00 | $0 | 0 |
| 2023-02-06 | Rosa David J. | EVP Chief Strategy & Growth Of |
Open-market sell
S
|
Common Stock | 45,025 | $250.53 | $11,280,023 | 125,385 |
| 2023-02-06 | Rosa David J. | EVP Chief Strategy & Growth Of |
Exercise / conversion
M
|
Common Stock | 54,000 | $63.25 | $3,415,262 | 170,410 |
| 2023-01-27 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 813 | $0.00 | $0 | 1,449 |
| 2023-01-27 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 816 | $0.00 | $0 | 1,269 |
| 2023-01-27 | DeSantis Robert | EVP & Chief Product Officer |
Open-market sell
S
|
Common Stock | 816 | $250.00 | $204,000 | 6,769 |
| 2023-01-27 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 816 | $177.99 | $145,237 | 7,585 |
| 2023-01-27 | DeSantis Robert | EVP & Chief Product Officer |
Open-market sell
S
|
Common Stock | 813 | $250.00 | $203,250 | 6,769 |
| 2023-01-27 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 813 | $179.70 | $146,096 | 7,582 |
| 2022-12-15 | Rosa David J. | EVP Chief Strategy & Growth Of |
Equity grant / award
G
|
Common Stock | 642 | $0.00 | $0 | 116,300 |
| 2022-11-08 | Johnson Amal M | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 6,375 | $0.00 | $0 | 0 |
| 2022-11-08 | Johnson Amal M | Dir |
Open-market sell
S
|
Common Stock | 6,375 | $239.36 | $1,525,904 | 11,224 |
| 2022-11-08 | Johnson Amal M | Dir |
Exercise / conversion
M
|
Common Stock | 6,375 | $53.76 | $342,692 | 17,599 |
| 2022-11-01 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 6,000 | $0.00 | $0 | 6,000 |
| 2022-11-01 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,000 | $0.00 | $0 | 6,500 |
| 2022-11-01 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 6,000 | $250.06 | $1,500,382 | 217 |
| 2022-11-01 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 6,000 | $174.26 | $1,045,540 | 6,217 |
| 2022-11-01 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 2,000 | $250.06 | $500,127 | 217 |
| 2022-11-01 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 2,000 | $166.62 | $333,247 | 2,217 |
| 2022-10-21 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 67,500 | $0.00 | $0 | 0 |
| 2022-10-21 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 44,203 | $210.84 | $9,319,610 | 23,297 |
| 2022-10-21 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 67,500 | $63.25 | $4,269,078 | 67,500 |
| 2022-10-10 | LOEB GARY | General Counsel & CCO |
Equity grant / award
A · derivative
|
Restricted Stock Units | 10,450 | $0.00 | $0 | 10,450 |
| 2022-10-10 | LOEB GARY | General Counsel and CCO |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 10,450 | $0.00 | $0 | 10,450 |
| 2022-09-08 | Johnson Amal M | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 6,375 | $0.00 | $0 | 6,375 |
| 2022-09-08 | Johnson Amal M | Dir |
Open-market sell
S
|
Common Stock | 6,375 | $210.76 | $1,343,584 | 11,224 |
| 2022-09-08 | Johnson Amal M | Dir |
Exercise / conversion
M
|
Common Stock | 6,375 | $53.76 | $342,692 | 17,599 |
| 2022-08-29 | Widman Fredrik | VP Corporate Controller |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 936 | $0.00 | $0 | 936 |
| 2022-08-15 | Ladd Amy L | Dir |
Open-market sell
S
|
Common Stock | 600 | $237.03 | $142,218 | 720 |
| 2022-08-03 | Johnson Amal M | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 6,375 | $0.00 | $0 | 12,750 |
| 2022-08-03 | Johnson Amal M | Dir |
Open-market sell
S
|
Common Stock | 6,375 | $238.04 | $1,517,487 | 11,224 |
| 2022-08-03 | Johnson Amal M | Dir |
Exercise / conversion
M
|
Common Stock | 6,375 | $53.76 | $342,692 | 17,599 |
| 2022-07-27 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 9,000 | $0.00 | $0 | 0 |
| 2022-07-27 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 9,000 | $225.00 | $2,025,000 | 217 |
| 2022-07-27 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 9,000 | $139.52 | $1,255,680 | 9,217 |
| 2022-07-26 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 126,000 | $0.00 | $0 | 0 |
| 2022-07-26 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 79,412 | $216.30 | $17,177,054 | 54,607 |
| 2022-07-26 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 126,000 | $57.48 | $7,242,341 | 134,019 |
| 2022-05-11 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 363 | $0.00 | $0 | 723 |
| 2022-05-11 | DeSantis Robert | EVP & Chief Product Officer |
Other disposed transaction
F
|
Common Stock | 169 | $210.87 | $35,637 | 6,768 |
| 2022-05-11 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 363 | $0.00 | $0 | 6,937 |
| 2022-04-28 | Ladd Amy L | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 482 | $0.00 | $0 | 482 |
| 2022-04-28 | Ladd Amy L | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 1,448 | $0.00 | $0 | 1,448 |
| 2022-04-26 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 795 | $0.00 | $0 | 6,750 |
| 2022-04-26 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 270 | $0.00 | $0 | 2,082 |
| 2022-04-26 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 273 | $0.00 | $0 | 2,262 |
| 2022-04-26 | DeSantis Robert | EVP & Chief Product Officer |
Open-market sell
S
|
Common Stock | 273 | $253.04 | $69,080 | 6,355 |
| 2022-04-26 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 273 | $177.99 | $48,590 | 6,628 |
| 2022-04-26 | DeSantis Robert | EVP & Chief Product Officer |
Open-market sell
S
|
Common Stock | 270 | $253.04 | $68,321 | 6,355 |
| 2022-04-26 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 270 | $242.34 | $65,431 | 6,625 |
| 2022-04-26 | DeSantis Robert | EVP & Chief Product Officer |
Open-market sell
S
|
Common Stock | 795 | $253.04 | $201,167 | 6,355 |
| 2022-04-26 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 795 | $245.60 | $195,252 | 7,150 |
| 2022-04-22 | Reed Monica P | Dir |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 555 | $0.00 | $0 | 0 |
| 2022-04-22 | Reed Monica P | Dir |
Exercise / conversion
M
|
Common Stock | 555 | $0.00 | $0 | 555 |
| 2022-02-28 | MOHR MARSHALL | Executive Vice President Glob |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 2,256 | $0.00 | $0 | 4,509 |
| 2022-02-28 | MOHR MARSHALL | Executive Vice President Glob |
Other disposed transaction
F
|
Common Stock | 1,119 | $290.33 | $324,879 | 4,532 |
| 2022-02-28 | MOHR MARSHALL | Executive Vice President Glob |
Exercise / conversion
M
|
Common Stock | 2,256 | $0.00 | $0 | 5,651 |
| 2022-02-28 | MOHR MARSHALL | Executive Vice President Glob |
Equity grant / award
A · derivative
|
Restricted Stock Units | 4,010 | $0.00 | $0 | 4,010 |
| 2022-02-28 | MOHR MARSHALL | Executive Vice President Glob |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 6,015 | $0.00 | $0 | 6,015 |
| 2022-02-26 | MOHR MARSHALL | Executive Vice President Glob |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,713 | $0.00 | $0 | 5,130 |
| 2022-02-26 | MOHR MARSHALL | Executive Vice President Glob |
Other disposed transaction
F
|
Common Stock | 850 | $293.51 | $249,484 | 3,395 |
| 2022-02-26 | MOHR MARSHALL | Executive Vice President Glob |
Exercise / conversion
M
|
Common Stock | 1,713 | $0.00 | $0 | 4,245 |
| 2022-02-15 | Charlton Henry L | Senior Vice President & Chief |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,311 | $0.00 | $0 | 1,311 |
| 2022-02-15 | Charlton Henry L | Senior Vice President & Chief |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,875 | $0.00 | $0 | 0 |
| 2022-02-15 | Charlton Henry L | Senior Vice President & Chief |
Other disposed transaction
F
|
Common Stock | 395 | $289.31 | $114,277 | 15,655 |
| 2022-02-15 | Charlton Henry L | Senior Vice President & Chief |
Exercise / conversion
M
|
Common Stock | 1,311 | $0.00 | $0 | 16,050 |
| 2022-02-15 | Charlton Henry L | Senior Vice President & Chief |
Other disposed transaction
F
|
Common Stock | 577 | $289.31 | $166,932 | 14,739 |
| 2022-02-15 | Charlton Henry L | Senior Vice President & Chief |
Exercise / conversion
M
|
Common Stock | 1,875 | $0.00 | $0 | 15,316 |
| 2022-01-25 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | $0 | 15,000 |
| 2022-01-25 | Curet Myriam | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 3,000 | $263.94 | $791,826 | 285 |
| 2022-01-25 | Curet Myriam | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 3,000 | $109.49 | $328,457 | 3,285 |
| 2021-12-14 | Rosa David J. | EVP and Chief Business Officer |
Equity grant / award
G
|
Common Stock | 250 | $0.00 | $0 | 111,953 |
| 2021-12-14 | Rosa David J. | EVP and Chief Business Officer |
Equity grant / award
G
|
Common Stock | 300 | $0.00 | $0 | 111,653 |
| 2021-11-24 | Johnson Amal M | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,500 | $0.00 | $0 | 0 |
| 2021-11-24 | Johnson Amal M | Dir |
Open-market sell
S
|
Common Stock | 7,500 | $333.73 | $2,502,954 | 10,669 |
| 2021-11-24 | Johnson Amal M | Dir |
Exercise / conversion
M
|
Common Stock | 7,500 | $64.36 | $482,700 | 18,169 |
| 2021-11-10 | Johnson Amal M | Dir |
Equity grant / award
G
|
Common Stock | 500 | $0.00 | $0 | 10,669 |
| 2021-10-25 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 20,475 | $0.00 | $0 | 0 |
| 2021-10-25 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 20,475 | $339.20 | $6,945,122 | 0 |
| 2021-10-25 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 20,475 | $59.23 | $1,212,689 | 20,475 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 156 | $0.00 | $0 | 1,515 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 321 | $0.00 | $0 | 432 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 273 | $0.00 | $0 | 1,449 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 324 | $0.00 | $0 | 432 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 324 | $339.66 | $110,048 | 762 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 324 | $139.52 | $45,204 | 1,086 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 321 | $339.66 | $109,029 | 762 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 321 | $174.26 | $55,936 | 1,083 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 273 | $339.66 | $92,726 | 762 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 273 | $182.83 | $49,913 | 1,035 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 156 | $339.66 | $52,986 | 762 |
| 2021-10-22 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 156 | $177.99 | $27,766 | 918 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 400 | $0.00 | $0 | 581 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 500 | $0.00 | $0 | 0 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 232 | $0.00 | $0 | 0 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 25 | $0.00 | $0 | 0 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 39 | $0.00 | $0 | 0 |
| 2021-09-09 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 400 | $1,083.16 | $433,264 | 4,815 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 400 | $213.97 | $85,588 | 5,215 |
| 2021-09-09 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 500 | $1,083.16 | $541,580 | 4,815 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 500 | $193.08 | $96,540 | 5,315 |
| 2021-09-09 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 25 | $1,083.16 | $27,079 | 4,815 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 25 | $161.27 | $4,032 | 4,840 |
| 2021-09-09 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 39 | $1,083.16 | $42,243 | 4,815 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 39 | $123.77 | $4,827 | 4,854 |
| 2021-09-09 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 232 | $1,083.16 | $251,293 | 4,815 |
| 2021-09-09 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 232 | $170.92 | $39,654 | 5,047 |
| 2021-08-26 | GUTHART GARY S | President & CEO |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 6,061 | $0.00 | $0 | 6,061 |
| 2021-08-11 | Johnson Amal M | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 2,500 |
| 2021-08-11 | Johnson Amal M | Dir |
Open-market sell
S
|
Common Stock | 2,500 | $1,001.63 | $2,504,087 | 3,723 |
| 2021-08-11 | Johnson Amal M | Dir |
Exercise / conversion
M
|
Common Stock | 2,500 | $193.08 | $482,700 | 6,223 |
| 2021-08-06 | Rosa David J. | EVP & Chief Business Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,500 | $0.00 | $0 | 0 |
| 2021-08-06 | Rosa David J. | EVP & Chief Business Officer |
Open-market sell
S
|
Common Stock | 8,065 | $1,011.90 | $8,160,977 | 37,501 |
| 2021-08-06 | Rosa David J. | EVP & Chief Business Officer |
Exercise / conversion
M
|
Common Stock | 10,500 | $172.44 | $1,810,585 | 45,566 |
| 2021-08-05 | Rosa David J. | EVP & Chief Business Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,500 | $0.00 | $0 | 10,500 |
| 2021-08-05 | Rosa David J. | EVP & Chief Business Officer |
Open-market sell
S
|
Common Stock | 8,146 | $1,007.23 | $8,204,927 | 35,066 |
| 2021-08-05 | Rosa David J. | EVP & Chief Business Officer |
Exercise / conversion
M
|
Common Stock | 10,500 | $172.44 | $1,810,585 | 43,212 |
| 2021-08-03 | Leonard Keith R | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 996 | $0.00 | $0 | 0 |
| 2021-08-03 | Leonard Keith R | Dir |
Open-market sell
S
|
Common Stock | 996 | $1,000.00 | $996,000 | 849 |
| 2021-08-03 | Leonard Keith R | Dir |
Exercise / conversion
M
|
Common Stock | 996 | $462.71 | $460,859 | 1,845 |
| 2021-07-26 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 6,825 | $0.00 | $0 | 0 |
| 2021-07-26 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 6,825 | $963.38 | $6,575,081 | 0 |
| 2021-07-26 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 6,825 | $171.33 | $1,169,350 | 6,825 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 484 | $0.00 | $0 | 965 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 422 | $0.00 | $0 | 1,026 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 483 | $0.00 | $0 | 967 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Open-market sell
S
|
Common Stock | 2,615 | $967.29 | $2,529,453 | 363 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Open-market sell
S
|
Common Stock | 483 | $967.23 | $467,172 | 2,978 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 483 | $533.96 | $257,903 | 3,461 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Open-market sell
S
|
Common Stock | 422 | $967.23 | $408,171 | 2,978 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 422 | $539.10 | $227,500 | 3,400 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Open-market sell
S
|
Common Stock | 484 | $967.21 | $468,129 | 2,978 |
| 2021-07-23 | DeSantis Robert | EVP & Chief Product Officer |
Exercise / conversion
M
|
Common Stock | 484 | $727.01 | $351,873 | 3,462 |
| 2021-06-15 | Rosa David J. | EVP and Chief Business Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 21,000 | $0.00 | $0 | 0 |
| 2021-06-15 | Rosa David J. | EVP and Chief Business Officer |
Open-market sell
S
|
Common Stock | 17,038 | $873.23 | $14,878,110 | 32,712 |
| 2021-06-15 | Rosa David J. | EVP and Chief Business Officer |
Exercise / conversion
M
|
Common Stock | 21,000 | $168.41 | $3,536,610 | 49,750 |
| 2021-05-12 | Johnson Amal M | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 5,000 |
| 2021-05-12 | Johnson Amal M | Dir |
Open-market sell
S
|
Common Stock | 2,500 | $817.82 | $2,044,557 | 3,723 |
| 2021-05-12 | Johnson Amal M | Dir |
Exercise / conversion
M
|
Common Stock | 2,500 | $193.08 | $482,700 | 6,223 |
| 2021-05-04 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 14,000 | $0.00 | $0 | 0 |
| 2021-05-04 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 10,617 | $851.99 | $9,045,591 | 3,383 |
| 2021-05-04 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 14,000 | $168.41 | $2,357,740 | 14,000 |
| 2021-04-26 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 21,000 | $0.00 | $0 | 0 |
| 2021-04-26 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 9,375 | $0.00 | $0 | 0 |
| 2021-04-26 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 12,588 | $865.74 | $10,897,902 | 8,412 |
| 2021-04-26 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 21,000 | $172.44 | $3,621,171 | 21,000 |
| 2021-04-26 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 9,375 | $865.63 | $8,115,320 | 0 |
| 2021-04-26 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 9,375 | $153.05 | $1,434,813 | 9,375 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 227 | $0.00 | $0 | 610 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 90 | $0.00 | $0 | 665 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 52 | $0.00 | $0 | 612 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 108 | $0.00 | $0 | 359 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 91 | $0.00 | $0 | 664 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 107 | $0.00 | $0 | 360 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 59 | $0.00 | $0 | 0 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 59 | $848.01 | $50,033 | 253 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 59 | $238.91 | $14,096 | 312 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 107 | $848.01 | $90,737 | 253 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 107 | $418.56 | $44,786 | 360 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 108 | $848.01 | $91,585 | 253 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 108 | $522.77 | $56,459 | 361 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 90 | $848.01 | $76,321 | 253 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 90 | $548.50 | $49,365 | 343 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 91 | $848.01 | $77,169 | 253 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 91 | $499.87 | $45,488 | 344 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 52 | $848.01 | $44,097 | 253 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 52 | $533.96 | $27,766 | 305 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 227 | $850.00 | $192,950 | 253 |
| 2021-04-23 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 227 | $727.01 | $165,031 | 480 |
| 2021-04-22 | RUBASH MARK J | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 185 | $0.00 | $0 | 185 |
| 2021-04-22 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 255 | $0.00 | $0 | 0 |
| 2021-04-22 | RUBASH MARK J | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 557 | $0.00 | $0 | 557 |
| 2021-04-22 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 255 | $0.00 | $0 | 4,815 |
| 2021-02-28 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,289 | $0.00 | $0 | 3,865 |
| 2021-02-28 | GUTHART GARY S | President & CEO |
Other disposed transaction
F
|
Common Stock | 640 | $0.00 | $0 | 5,981 |
| 2021-02-28 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 1,289 | $0.00 | $0 | 6,621 |
| 2021-02-26 | GUTHART GARY S | President & CEO |
Equity grant / award
A · derivative
|
Restricted Stock Units | 4,040 | $0.00 | $0 | 4,040 |
| 2021-02-26 | GUTHART GARY S | President & CEO |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 6,061 | $0.00 | $0 | 6,061 |
| 2021-02-17 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,485 | $782.00 | $1,161,270 | 94 |
| 2021-02-15 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 583 | $0.00 | $0 | 1,166 |
| 2021-02-15 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,000 | $0.00 | $0 | 1,000 |
| 2021-02-15 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 999 | $0.00 | $0 | 0 |
| 2021-02-15 | Myriam Curet | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 207 | $0.00 | $0 | 1,579 |
| 2021-02-15 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 583 | $0.00 | $0 | 1,786 |
| 2021-02-15 | Myriam Curet | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 394 | $0.00 | $0 | 1,203 |
| 2021-02-15 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,000 | $0.00 | $0 | 1,597 |
| 2021-02-15 | Myriam Curet | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 496 | $0.00 | $0 | 597 |
| 2021-02-15 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 999 | $0.00 | $0 | 1,093 |
| 2021-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 583 | $0.00 | $0 | 3,499 |
| 2021-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 708 | $0.00 | $0 | 708 |
| 2021-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,250 | $0.00 | $0 | 0 |
| 2021-02-15 | MOHR MARSHALL | Executive VP & CFO |
Other disposed transaction
F
|
Common Stock | 620 | $0.00 | $0 | 9,840 |
| 2021-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 1,250 | $172.44 | $215,546 | 11,090 |
| 2021-02-15 | MOHR MARSHALL | Executive VP & CFO |
Other disposed transaction
F
|
Common Stock | 352 | $0.00 | $0 | 9,210 |
| 2021-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 708 | $0.00 | $0 | 9,562 |
| 2021-02-15 | MOHR MARSHALL | Executive VP & CFO |
Other disposed transaction
F
|
Common Stock | 290 | $0.00 | $0 | 8,854 |
| 2021-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 583 | $0.00 | $0 | 9,144 |
| 2021-02-11 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 21,000 | $0.00 | $0 | 0 |
| 2021-02-11 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 12,487 | $800.00 | $9,989,602 | 8,561 |
| 2021-02-11 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 21,000 | $168.41 | $3,536,610 | 21,048 |
| 2021-02-02 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 14,000 | $0.00 | $0 | 14,000 |
| 2021-02-02 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 11,020 | $762.14 | $8,398,759 | 2,980 |
| 2021-02-02 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 14,000 | $168.41 | $2,357,740 | 14,000 |
| 2021-01-29 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 9,375 | $0.00 | $0 | 0 |
| 2021-01-29 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 9,375 | $751.66 | $7,046,858 | 48 |
| 2021-01-29 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 9,375 | $148.03 | $1,387,781 | 9,423 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 61 | $0.00 | $0 | 755 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 18 | $0.00 | $0 | 664 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 60 | $0.00 | $0 | 755 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 72 | $0.00 | $0 | 467 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 119 | $0.00 | $0 | 59 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 119 | $754.48 | $89,783 | 207 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 119 | $238.91 | $28,431 | 326 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 72 | $754.48 | $54,323 | 207 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 72 | $418.56 | $30,136 | 279 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 61 | $754.48 | $46,023 | 207 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 61 | $548.50 | $33,458 | 268 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 60 | $754.48 | $45,269 | 207 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 60 | $499.87 | $29,992 | 267 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 18 | $754.48 | $13,581 | 207 |
| 2021-01-26 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 18 | $533.96 | $9,611 | 225 |
| 2020-12-09 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 2,900 | $758.41 | $2,199,394 | 11,600 |
| 2020-12-08 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 14,000 | $0.00 | $0 | 28,000 |
| 2020-12-08 | GUTHART GARY S | President & CEO |
Equity grant / award
G
|
Common Stock | 14,500 | $0.00 | $0 | 14,500 |
| 2020-12-08 | GUTHART GARY S | President & CEO |
Equity grant / award
G
|
Common Stock | 35,800 | $0.00 | $0 | 108,757 |
| 2020-12-08 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 11,114 | $761.76 | $8,466,228 | 252,197 |
| 2020-12-08 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 14,000 | $168.41 | $2,357,740 | 263,311 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 156 | $0.00 | $0 | 682 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 30 | $0.00 | $0 | 816 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 36 | $0.00 | $0 | 539 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 59 | $0.00 | $0 | 178 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 60 | $0.00 | $0 | 178 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 156 | $778.00 | $121,368 | 207 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 156 | $533.96 | $83,298 | 363 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 30 | $778.00 | $23,340 | 207 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 30 | $499.87 | $14,996 | 237 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 60 | $778.00 | $46,680 | 207 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 60 | $238.91 | $14,335 | 267 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 59 | $778.00 | $45,902 | 207 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 59 | $328.46 | $19,379 | 266 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 36 | $778.00 | $28,008 | 207 |
| 2020-12-07 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 36 | $418.56 | $15,068 | 243 |
| 2020-12-01 | MOHR MARSHALL | Executive VP & CFO |
Equity grant / award
G
|
Common Stock | 1,400 | $0.00 | $0 | 13,273 |
| 2020-10-26 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 6,000 | $0.00 | $0 | 0 |
| 2020-10-26 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 6,000 | $715.28 | $4,291,690 | 14,673 |
| 2020-10-26 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 6,000 | $127.91 | $767,460 | 20,673 |
| 2020-10-20 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 875 | $0.00 | $0 | 2,125 |
| 2020-10-20 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 875 | $736.12 | $644,105 | 2,986 |
| 2020-10-20 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 875 | $238.91 | $209,049 | 3,861 |
| 2020-09-10 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,250 | $0.00 | $0 | 3,250 |
| 2020-09-10 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Open-market sell
S
|
Common Stock | 264 | $718.50 | $189,684 | 4,068 |
| 2020-09-10 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Open-market sell
S
|
Common Stock | 1,250 | $718.50 | $898,125 | 4,332 |
| 2020-09-10 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Exercise / conversion
M
|
Common Stock | 1,250 | $170.76 | $213,446 | 5,582 |
| 2020-08-31 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,000 | $0.00 | $0 | 500 |
| 2020-08-31 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 1,000 | $723.73 | $723,730 | 4,560 |
| 2020-08-31 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 1,000 | $193.08 | $193,080 | 5,560 |
| 2020-08-28 | MOHR MARSHALL | Executive VP & CFO |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 4,510 | $0.00 | $0 | 4,510 |
| 2020-08-25 | Johnson Amal M | Dir |
Equity grant / award
G
|
Common Stock | 6,000 | $0.00 | $0 | 3,468 |
| 2020-08-18 | Myriam Curet | EVP & Chief Medical Officer |
Equity grant / award
G
|
Common Stock | 80 | $0.00 | $0 | 2,986 |
| 2020-08-05 | Rosa David J. | EVP and Chief Business Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 24,000 | $0.00 | $0 | 0 |
| 2020-08-05 | Rosa David J. | EVP and Chief Business Officer |
Open-market sell
S
|
Common Stock | 16,840 | $693.02 | $11,670,416 | 26,479 |
| 2020-08-05 | Rosa David J. | EVP and Chief Business Officer |
Exercise / conversion
M
|
Common Stock | 24,000 | $113.73 | $2,729,520 | 43,319 |
| 2020-07-27 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,500 | $0.00 | $0 | 6,000 |
| 2020-07-27 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 7,500 | $677.19 | $5,078,930 | 14,672 |
| 2020-07-27 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 7,500 | $127.91 | $959,325 | 22,172 |
| 2020-07-24 | DeSantis Robert | Executive VP & GM IA&E |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 382 | $0.00 | $0 | 0 |
| 2020-07-24 | DeSantis Robert | Executive VP & GM IA&E |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 383 | $0.00 | $0 | 0 |
| 2020-07-24 | DeSantis Robert | Executive VP & GM IA&E |
Open-market sell
S
|
Common Stock | 383 | $665.57 | $254,913 | 3,348 |
| 2020-07-24 | DeSantis Robert | Executive VP & GM IA&E |
Exercise / conversion
M
|
Common Stock | 383 | $178.39 | $68,322 | 3,731 |
| 2020-07-24 | DeSantis Robert | Executive VP & GM IA&E |
Open-market sell
S
|
Common Stock | 382 | $665.57 | $254,247 | 3,348 |
| 2020-07-24 | DeSantis Robert | Executive VP & GM IA&E |
Exercise / conversion
M
|
Common Stock | 382 | $231.00 | $88,241 | 3,730 |
| 2020-07-24 | DeSantis Robert | Executive VP & GM IA&E |
Open-market sell
S
|
Common Stock | 1,033 | $666.69 | $688,688 | 3,348 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 90 | $0.00 | $0 | 937 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 107 | $0.00 | $0 | 683 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 91 | $0.00 | $0 | 936 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 108 | $0.00 | $0 | 683 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 178 | $0.00 | $0 | 415 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 90 | $663.33 | $59,700 | 207 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 90 | $548.50 | $49,365 | 297 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 91 | $663.33 | $60,363 | 207 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 91 | $499.87 | $45,488 | 298 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 178 | $663.33 | $118,073 | 207 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 178 | $238.91 | $42,527 | 385 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 108 | $663.33 | $71,640 | 207 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 108 | $418.56 | $45,204 | 315 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 107 | $663.33 | $70,976 | 207 |
| 2020-07-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 107 | $522.77 | $55,936 | 314 |
| 2020-06-15 | Rosa David J. | EVP and Chief Business Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 24,000 | $0.00 | $0 | 24,000 |
| 2020-06-15 | Rosa David J. | EVP and Chief Business Officer |
Open-market sell
S
|
Common Stock | 17,950 | $553.49 | $9,935,205 | 19,319 |
| 2020-06-15 | Rosa David J. | EVP and Chief Business Officer |
Exercise / conversion
M
|
Common Stock | 24,000 | $113.73 | $2,729,520 | 37,269 |
| 2020-06-05 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 91 | $0.00 | $0 | 1,027 |
| 2020-06-05 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 108 | $0.00 | $0 | 790 |
| 2020-06-05 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 90 | $0.00 | $0 | 1,027 |
| 2020-06-05 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 108 | $600.00 | $64,800 | 207 |
| 2020-06-05 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 108 | $522.77 | $56,459 | 315 |
| 2020-06-05 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 91 | $600.00 | $54,600 | 207 |
| 2020-06-05 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 91 | $548.50 | $49,914 | 298 |
| 2020-06-05 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 90 | $600.00 | $54,000 | 207 |
| 2020-06-05 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 90 | $499.87 | $44,988 | 297 |
| 2020-05-26 | LEVY ALAN J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,950 | $0.00 | $0 | 3,600 |
| 2020-05-26 | LEVY ALAN J | Dir |
Open-market sell
S
|
Common Stock | 1,950 | $575.00 | $1,121,250 | 7,839 |
| 2020-05-26 | LEVY ALAN J | Dir |
Exercise / conversion
M
|
Common Stock | 1,950 | $193.08 | $376,506 | 9,789 |
| 2020-05-20 | Johnson Amal M | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | $0 | 0 |
| 2020-05-20 | Johnson Amal M | Dir |
Open-market sell
S
|
Common Stock | 3,000 | $550.00 | $1,650,000 | 9,468 |
| 2020-05-20 | Johnson Amal M | Dir |
Exercise / conversion
M
|
Common Stock | 3,000 | $119.06 | $357,190 | 12,468 |
| 2020-05-11 | DeSantis Robert | Executive VP & GM IA&E |
Equity grant / award
A · derivative
|
Restricted Stock Units | 483 | $0.00 | $0 | 483 |
| 2020-05-11 | DeSantis Robert | Executive VP & GM IA&E |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 1,448 | $0.00 | $0 | 1,448 |
| 2020-05-05 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 31,875 | $0.00 | $0 | 0 |
| 2020-05-05 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 23,430 | $510.38 | $11,958,147 | 393,868 |
| 2020-05-05 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 31,875 | $113.73 | $3,625,144 | 417,298 |
| 2020-04-29 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 4,500 | $0.00 | $0 | 13,500 |
| 2020-04-29 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | $0 | 0 |
| 2020-04-29 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 4,500 | $525.00 | $2,362,500 | 14,672 |
| 2020-04-29 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 4,500 | $127.91 | $575,595 | 19,172 |
| 2020-04-29 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 3,000 | $525.00 | $1,575,000 | 14,672 |
| 2020-04-29 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 3,000 | $113.73 | $341,190 | 17,672 |
| 2020-04-23 | Beery Joseph C | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 255 | $0.00 | $0 | 255 |
| 2020-04-23 | Beery Joseph C | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 766 | $0.00 | $0 | 766 |
| 2020-04-22 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 750 | $0.00 | $0 | 3,000 |
| 2020-04-22 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,500 | $0.00 | $0 | 450 |
| 2020-04-22 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,500 | $503.76 | $755,640 | 3,066 |
| 2020-04-22 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,500 | $189.74 | $284,605 | 4,566 |
| 2020-04-22 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 750 | $503.76 | $377,820 | 3,066 |
| 2020-04-22 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 750 | $231.00 | $173,248 | 3,816 |
| 2020-04-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 178 | $0.00 | $0 | 594 |
| 2020-04-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 36 | $0.00 | $0 | 0 |
| 2020-04-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 34 | $0.00 | $0 | 0 |
| 2020-04-21 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 34 | $506.18 | $17,210 | 207 |
| 2020-04-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 34 | $178.39 | $6,065 | 241 |
| 2020-04-21 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 36 | $506.18 | $18,222 | 207 |
| 2020-04-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 36 | $231.00 | $8,316 | 243 |
| 2020-04-21 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 178 | $506.18 | $90,100 | 207 |
| 2020-04-21 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 178 | $238.91 | $42,527 | 385 |
| 2020-02-28 | Myriam Curet | EVP & Chief Medical Officer |
Equity grant / award
A · derivative
|
Restricted Stock Units | 3,007 | $0.00 | $0 | 3,007 |
| 2020-02-28 | Myriam Curet | EVP & Chief Medical Officer |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 4,510 | $0.00 | $0 | 4,510 |
| 2020-02-16 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,875 | $0.00 | $0 | 1,875 |
| 2020-02-16 | MOHR MARSHALL | Executive VP & CFO |
Other disposed transaction
F
|
Common Stock | 930 | $0.00 | $0 | 14,672 |
| 2020-02-16 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 1,875 | $0.00 | $0 | 15,602 |
| 2020-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 584 | $0.00 | $0 | 4,082 |
| 2020-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 708 | $0.00 | $0 | 0 |
| 2020-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,250 | $0.00 | $0 | 0 |
| 2020-02-15 | MOHR MARSHALL | Executive VP & CFO |
Other disposed transaction
F
|
Common Stock | 290 | $0.00 | $0 | 13,727 |
| 2020-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 584 | $0.00 | $0 | 14,017 |
| 2020-02-15 | MOHR MARSHALL | Executive VP & CFO |
Other disposed transaction
F
|
Common Stock | 352 | $0.00 | $0 | 13,433 |
| 2020-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 708 | $0.00 | $0 | 13,785 |
| 2020-02-15 | MOHR MARSHALL | Executive VP & CFO |
Other disposed transaction
F
|
Common Stock | 620 | $0.00 | $0 | 13,077 |
| 2020-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 1,250 | $0.00 | $0 | 13,697 |
| 2020-02-14 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 12,537 | $600.72 | $7,531,240 | 298,523 |
| 2020-02-14 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 4,700 | $0.00 | $0 | 276,714 |
| 2020-02-14 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 15,663 | $600.72 | $9,409,095 | 281,414 |
| 2020-02-13 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 3,463 | $600.30 | $2,078,849 | 311,060 |
| 2020-02-13 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 1,300 | $0.00 | $0 | 297,077 |
| 2020-02-13 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 4,337 | $600.30 | $2,603,514 | 298,377 |
| 2020-02-13 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 332 | $0.00 | $0 | 1,118 |
| 2020-02-13 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 827 | $0.00 | $0 | 898 |
| 2020-02-13 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 333 | $0.00 | $0 | 1,117 |
| 2020-02-13 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 827 | $600.00 | $496,200 | 207 |
| 2020-02-13 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 827 | $522.77 | $432,331 | 1,034 |
| 2020-02-13 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 332 | $600.00 | $199,200 | 207 |
| 2020-02-13 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 332 | $548.50 | $182,102 | 539 |
| 2020-02-13 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 333 | $600.00 | $199,800 | 207 |
| 2020-02-13 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 333 | $499.87 | $166,457 | 540 |
| 2020-02-12 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 227 | $592.78 | $134,562 | 314,523 |
| 2020-02-05 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 31,875 | $0.00 | $0 | 31,875 |
| 2020-02-05 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 22,233 | $576.56 | $12,818,678 | 381,370 |
| 2020-02-05 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 31,875 | $113.73 | $3,625,144 | 403,603 |
| 2020-02-03 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,500 | $0.00 | $0 | 3,000 |
| 2020-02-03 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 7,500 | $563.21 | $4,224,056 | 12,447 |
| 2020-02-03 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 7,500 | $113.73 | $852,975 | 19,947 |
| 2020-01-29 | LEVY ALAN J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,950 | $0.00 | $0 | 5,550 |
| 2020-01-29 | LEVY ALAN J | Dir |
Open-market sell
S
|
Common Stock | 1,950 | $575.00 | $1,121,250 | 7,577 |
| 2020-01-29 | LEVY ALAN J | Dir |
Exercise / conversion
M
|
Common Stock | 1,950 | $193.08 | $376,506 | 9,527 |
| 2020-01-28 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 9,179 | $0.00 | $0 | 314,750 |
| 2020-01-28 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 10,750 | $0.00 | $0 | 323,929 |
| 2020-01-28 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 13,012 | $0.00 | $0 | 334,679 |
| 2019-12-10 | Rosa David J. | EVP and Chief Business Officer |
Equity grant / award
G
|
Common Stock | 267 | $0.00 | $0 | 10,093 |
| 2019-12-09 | GUTHART GARY S | President & CEO |
Equity grant / award
G
|
Common Stock | 2,000 | $0.00 | $0 | 371,728 |
| 2019-12-06 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 59 | $0.00 | $0 | 890 |
| 2019-12-06 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 36 | $0.00 | $0 | 971 |
| 2019-12-06 | Samath Jamie | SVP of Finance |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 35 | $0.00 | $0 | 105 |
| 2019-12-06 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 35 | $584.63 | $20,462 | 159 |
| 2019-12-06 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 35 | $178.39 | $6,244 | 194 |
| 2019-12-06 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 59 | $584.63 | $34,493 | 159 |
| 2019-12-06 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 59 | $238.91 | $14,096 | 218 |
| 2019-12-06 | Samath Jamie | SVP of Finance |
Open-market sell
S
|
Common Stock | 36 | $584.63 | $21,047 | 159 |
| 2019-12-06 | Samath Jamie | SVP of Finance |
Exercise / conversion
M
|
Common Stock | 36 | $231.00 | $8,316 | 195 |
| 2019-12-05 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 31,875 | $0.00 | $0 | 63,750 |
| 2019-12-05 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 22,377 | $582.12 | $13,026,084 | 373,728 |
| 2019-12-05 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 31,875 | $113.73 | $3,625,144 | 396,105 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 843 | $0.00 | $0 | 3,657 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,735 | $0.00 | $0 | 3,515 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 844 | $0.00 | $0 | 3,656 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,734 | $0.00 | $0 | 3,516 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,812 | $0.00 | $0 | 2,812 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 563 | $0.00 | $0 | 2,811 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 305 | $0.00 | $0 | 305 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 304 | $0.00 | $0 | 305 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 1,228 | $592.00 | $726,976 | 4,143 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 304 | $586.66 | $178,344 | 5,371 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 304 | $178.39 | $54,230 | 5,675 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 305 | $586.66 | $178,930 | 5,371 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 305 | $231.00 | $70,454 | 5,676 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 563 | $586.66 | $330,288 | 5,371 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 563 | $238.91 | $134,508 | 5,934 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 2,812 | $586.66 | $1,649,679 | 5,371 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 2,812 | $328.46 | $923,620 | 8,183 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 2,734 | $586.66 | $1,603,920 | 5,371 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 2,734 | $418.56 | $1,144,343 | 8,105 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 2,735 | $586.69 | $1,604,587 | 5,371 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 2,735 | $522.77 | $1,429,776 | 8,106 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 844 | $586.69 | $495,163 | 5,371 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 844 | $499.87 | $421,890 | 6,215 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 843 | $586.69 | $494,576 | 5,371 |
| 2019-12-02 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 843 | $548.50 | $462,386 | 6,214 |
| 2019-11-26 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 60,000 | $0.00 | $0 | 347,691 |
| 2019-11-19 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,000 | $0.00 | $0 | 1,500 |
| 2019-11-19 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 1,000 | $580.00 | $580,000 | 4,298 |
| 2019-11-19 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 1,000 | $193.08 | $193,080 | 5,298 |
| 2019-11-13 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 2,965 | $0.00 | $0 | 287,691 |
| 2019-11-13 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 84 | $0.00 | $0 | 290,656 |
| 2019-11-08 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 205 | $554.49 | $113,670 | 260,656 |
| 2019-11-04 | Rosa David J. | EVP and Chief Business Officer |
Equity grant / award
G
|
Common Stock | 1,884 | $0.00 | $0 | 10,360 |
| 2019-11-01 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 290,861 |
| 2019-10-31 | Myriam Curet | EVP & Chief Medical Officer |
Equity grant / award
G
|
Common Stock | 83 | $0.00 | $0 | 3,018 |
| 2019-10-28 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,500 | $0.00 | $0 | 10,500 |
| 2019-10-28 | MOHR MARSHALL | Executive VP & CFO |
Equity grant / award
G
|
Common Stock | 234 | $0.00 | $0 | 12,401 |
| 2019-10-28 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 7,500 | $548.43 | $4,113,258 | 12,635 |
| 2019-10-28 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 7,500 | $113.73 | $852,975 | 20,135 |
| 2019-10-23 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 743 | $0.00 | $0 | 260,861 |
| 2019-10-22 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 750 | $0.00 | $0 | 4,500 |
| 2019-10-22 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,500 | $0.00 | $0 | 3,450 |
| 2019-10-22 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,500 | $553.92 | $830,880 | 3,101 |
| 2019-10-22 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,500 | $189.74 | $284,605 | 4,601 |
| 2019-10-22 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 750 | $553.92 | $415,440 | 3,101 |
| 2019-10-22 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 750 | $231.00 | $173,248 | 3,851 |
| 2019-09-03 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 562 | $0.00 | $0 | 3,374 |
| 2019-09-03 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 304 | $0.00 | $0 | 610 |
| 2019-09-03 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 305 | $0.00 | $0 | 609 |
| 2019-09-03 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 305 | $505.23 | $154,095 | 5,371 |
| 2019-09-03 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 305 | $178.39 | $54,408 | 5,676 |
| 2019-09-03 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 304 | $505.23 | $153,590 | 5,371 |
| 2019-09-03 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 304 | $231.00 | $70,223 | 5,675 |
| 2019-09-03 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 562 | $505.23 | $283,939 | 5,371 |
| 2019-09-03 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 562 | $238.91 | $134,269 | 5,933 |
| 2019-08-20 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 215 | $493.18 | $106,034 | 261,604 |
| 2019-08-19 | Samath Jamie | VP & Principal Accounting Offi |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 60 | $0.00 | $0 | 1,069 |
| 2019-08-19 | Samath Jamie | VP & Principal Accounting Offi |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 35 | $0.00 | $0 | 212 |
| 2019-08-19 | Samath Jamie | VP & Principal Accounting Offi |
Open-market sell
S
|
Common Stock | 35 | $503.50 | $17,622 | 159 |
| 2019-08-19 | Samath Jamie | VP & Principal Accounting Offi |
Exercise / conversion
M
|
Common Stock | 35 | $178.39 | $6,244 | 194 |
| 2019-08-19 | Samath Jamie | VP & Principal Accounting Offi |
Open-market sell
S
|
Common Stock | 60 | $503.50 | $30,210 | 159 |
| 2019-08-19 | Samath Jamie | VP & Principal Accounting Offi |
Exercise / conversion
M
|
Common Stock | 60 | $238.91 | $14,335 | 219 |
| 2019-08-15 | GUTHART GARY S | President & CEO |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 7,500 | $0.00 | $0 | 7,500 |
| 2019-08-02 | Ladd Amy L | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 183 | $0.00 | $0 | 183 |
| 2019-08-02 | Ladd Amy L | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 550 | $0.00 | $0 | 550 |
| 2019-07-31 | KANIA DON R | Dir |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 215 | $0.00 | $0 | 0 |
| 2019-07-31 | KANIA DON R | Dir |
Exercise / conversion
M
|
Common Stock | 215 | $0.00 | $0 | 215 |
| 2019-07-29 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,500 | $0.00 | $0 | 18,000 |
| 2019-07-29 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 7,500 | $526.09 | $3,945,640 | 12,635 |
| 2019-07-29 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 7,500 | $113.73 | $852,975 | 20,135 |
| 2019-07-24 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | $0 | 6,000 |
| 2019-07-24 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Open-market sell
S
|
Common Stock | 1,120 | $540.00 | $604,800 | 3,718 |
| 2019-07-24 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Open-market sell
S
|
Common Stock | 3,000 | $540.00 | $1,620,000 | 4,838 |
| 2019-07-24 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Exercise / conversion
M
|
Common Stock | 3,000 | $170.76 | $512,270 | 7,838 |
| 2019-07-24 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 3,000 | $0.00 | $0 | 6,000 |
| 2019-07-24 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Open-market sell
S
|
Common Stock | 1,120 | $540.00 | $604,800 | 3,718 |
| 2019-07-24 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Open-market sell
S
|
Common Stock | 3,000 | $540.00 | $1,620,000 | 4,838 |
| 2019-07-24 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Exercise / conversion
M
|
Common Stock | 3,000 | $170.76 | $512,270 | 7,838 |
| 2019-07-23 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 15,943 | $0.00 | $0 | 283,546 |
| 2019-07-23 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 15,614 | $0.00 | $0 | 299,489 |
| 2019-07-23 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 14,000 | $0.00 | $0 | 261,819 |
| 2019-07-23 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 7,727 | $0.00 | $0 | 275,819 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,500 | $0.00 | $0 | 4,950 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 750 | $0.00 | $0 | 5,250 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 611 | $0.00 | $0 | 0 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 613 | $0.00 | $0 | 0 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,500 | $532.14 | $798,210 | 3,101 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,500 | $189.74 | $284,605 | 4,601 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 613 | $532.14 | $326,202 | 3,101 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 613 | $171.33 | $105,027 | 3,714 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 611 | $532.14 | $325,138 | 3,101 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 611 | $177.68 | $108,564 | 3,712 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 750 | $532.14 | $399,105 | 3,101 |
| 2019-07-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 750 | $178.39 | $133,790 | 3,851 |
| 2019-06-10 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 562 | $0.00 | $0 | 3,936 |
| 2019-06-10 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 305 | $0.00 | $0 | 914 |
| 2019-06-10 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 305 | $500.60 | $152,683 | 5,371 |
| 2019-06-10 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 305 | $178.39 | $54,408 | 5,676 |
| 2019-06-10 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 562 | $500.60 | $281,337 | 5,371 |
| 2019-06-10 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 562 | $238.91 | $134,269 | 5,933 |
| 2019-05-23 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 315,103 |
| 2019-05-16 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 227 | $493.39 | $112,000 | 286,275 |
| 2019-05-06 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 30,833 | $0.00 | $0 | 0 |
| 2019-05-06 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 22,636 | $501.48 | $11,351,596 | 364,230 |
| 2019-05-06 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 30,833 | $111.43 | $3,435,823 | 386,866 |
| 2019-04-25 | LEVY ALAN J | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 262 | $0.00 | $0 | 262 |
| 2019-04-25 | LEVY ALAN J | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 786 | $0.00 | $0 | 786 |
| 2019-04-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,200 | $0.00 | $0 | 6,450 |
| 2019-04-23 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 2,200 | $493.26 | $1,085,179 | 3,101 |
| 2019-04-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 2,200 | $189.74 | $417,421 | 5,301 |
| 2019-04-23 | Friedman Michael A | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 996 | $0.00 | $0 | 0 |
| 2019-04-23 | Friedman Michael A | Dir |
Open-market sell
S
|
Common Stock | 996 | $500.00 | $498,000 | 4,751 |
| 2019-04-23 | Friedman Michael A | Dir |
Exercise / conversion
M
|
Common Stock | 996 | $462.71 | $460,859 | 5,747 |
| 2019-04-19 | NACHTSHEIM JAMI K | Dir |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 332 | $0.00 | $0 | 0 |
| 2019-04-19 | NACHTSHEIM JAMI K | Dir |
Exercise / conversion
M
|
Common Stock | 332 | $0.00 | $0 | 845 |
| 2019-03-08 | Myriam Curet | EVP & Chief Medical Officer |
Equity grant / award
G
|
Common Stock | 41 | $0.00 | $0 | 3,101 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 563 | $0.00 | $0 | 4,498 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 305 | $0.00 | $0 | 1,219 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 458 | $0.00 | $0 | 0 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 459 | $0.00 | $0 | 0 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 459 | $551.79 | $253,273 | 5,371 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 459 | $171.33 | $78,642 | 5,830 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 458 | $551.79 | $252,721 | 5,371 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 458 | $177.68 | $81,379 | 5,829 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 305 | $551.79 | $168,297 | 5,371 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 305 | $178.39 | $54,408 | 5,676 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 563 | $551.79 | $310,659 | 5,371 |
| 2019-03-01 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 563 | $238.91 | $134,508 | 5,934 |
| 2019-02-26 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 210 | $546.55 | $114,777 | 286,502 |
| 2019-02-19 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 2,938 | $543.51 | $1,596,844 | 94 |
| 2019-02-15 | Brogna Salvatore | EVP & Chief Operating Officer |
Equity grant / award
A · derivative
|
Restricted Stock Units | 3,000 | $0.00 | $0 | 3,000 |
| 2019-02-15 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,042 | $0.00 | $0 | 3,125 |
| 2019-02-15 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,500 | $0.00 | $0 | 3,000 |
| 2019-02-15 | Brogna Salvatore | EVP & Chief Operating Officer |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 4,500 | $0.00 | $0 | 4,500 |
| 2019-02-15 | Brogna Salvatore | EVP & Chief Operating Officer |
Other disposed transaction
F
|
Common Stock | 517 | $0.00 | $0 | 2,917 |
| 2019-02-15 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 1,042 | $0.00 | $0 | 3,434 |
| 2019-02-15 | Brogna Salvatore | EVP & Chief Operating Officer |
Other disposed transaction
F
|
Common Stock | 595 | $0.00 | $0 | 2,392 |
| 2019-02-15 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 1,500 | $0.00 | $0 | 2,987 |
| 2019-02-15 | MOHR MARSHALL | Executive VP & CFO |
Other disposed transaction
F
|
Common Stock | 972 | $548.50 | $533,142 | 10,626 |
| 2019-02-15 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 1,959 | $0.00 | $0 | 11,598 |
| 2019-02-06 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 750 | $0.00 | $0 | 0 |
| 2019-02-06 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Other disposed transaction
F
|
Common Stock | 271 | $521.95 | $141,448 | 3,788 |
| 2019-02-06 | Andersen Reiter Kara | Sr VP General Counsel & CCO |
Exercise / conversion
M
|
Common Stock | 750 | $0.00 | $0 | 4,059 |
| 2019-02-05 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,500 | $0.00 | $0 | 33,000 |
| 2019-02-05 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 7,500 | $525.00 | $3,937,500 | 9,559 |
| 2019-02-05 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 7,500 | $113.73 | $852,975 | 17,059 |
| 2019-02-04 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 40,833 | $0.00 | $0 | 30,833 |
| 2019-02-04 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 28,152 | $520.47 | $14,652,190 | 351,300 |
| 2019-02-04 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 40,833 | $111.43 | $4,550,156 | 379,452 |
| 2019-01-29 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 10,071 | $0.00 | $0 | 286,712 |
| 2018-12-12 | Rosa David J. | EVP & Chief Commercial Officer |
Equity grant / award
G
|
Common Stock | 3,354 | $0.00 | $0 | 8,354 |
| 2018-12-03 | GUTHART GARY S | President & CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 40,834 | $0.00 | $0 | 71,666 |
| 2018-12-03 | GUTHART GARY S | President & CEO |
Equity grant / award
G
|
Common Stock | 2,000 | $0.00 | $0 | 338,619 |
| 2018-12-03 | GUTHART GARY S | President & CEO |
Open-market sell
S
|
Common Stock | 28,085 | $542.78 | $15,243,920 | 340,619 |
| 2018-12-03 | GUTHART GARY S | President & CEO |
Exercise / conversion
M
|
Common Stock | 40,834 | $111.43 | $4,550,267 | 368,704 |
| 2018-11-11 | Myriam Curet | EVP & Chief Medical Officer |
Equity grant / award
G
|
Common Stock | 40 | $0.00 | $0 | 1,900 |
| 2018-11-07 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 225 | $540.04 | $121,509 | 266,783 |
| 2018-11-05 | MOHR MARSHALL | Executive VP & CFO |
Equity grant / award
G
|
Common Stock | 262 | $0.00 | $0 | 9,559 |
| 2018-10-31 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,500 | $0.00 | $0 | 40,500 |
| 2018-10-31 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 7,500 | $525.00 | $3,937,500 | 9,821 |
| 2018-10-31 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 7,500 | $113.73 | $852,975 | 17,321 |
| 2018-10-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,100 | $0.00 | $0 | 8,650 |
| 2018-10-23 | Myriam Curet | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 1,100 | $498.28 | $548,103 | 1,940 |
| 2018-10-23 | Myriam Curet | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,100 | $189.74 | $208,710 | 3,040 |
| 2018-10-23 | Johnson Amal M | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,000 | $0.00 | $0 | 7,250 |
| 2018-10-23 | Johnson Amal M | Dir |
Open-market sell
S
|
Common Stock | 1,000 | $500.00 | $500,000 | 8,874 |
| 2018-10-23 | Johnson Amal M | Dir |
Exercise / conversion
M
|
Common Stock | 1,000 | $119.06 | $119,063 | 9,874 |
| 2018-09-14 | Myriam Curet | EVP & Chief Medical Officer |
Equity grant / award
G
|
Common Stock | 30 | $0.00 | $0 | 1,940 |
| 2018-09-07 | Friedman Michael A | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,545 | $0.00 | $0 | 0 |
| 2018-09-07 | Friedman Michael A | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 525 | $0.00 | $0 | 0 |
| 2018-09-07 | Friedman Michael A | Dir |
Open-market sell
S
|
Common Stock | 525 | $541.46 | $284,266 | 4,419 |
| 2018-09-07 | Friedman Michael A | Dir |
Exercise / conversion
M
|
Common Stock | 525 | $185.73 | $97,510 | 4,944 |
| 2018-09-07 | Friedman Michael A | Dir |
Open-market sell
S
|
Common Stock | 1,545 | $541.46 | $836,554 | 4,419 |
| 2018-09-07 | Friedman Michael A | Dir |
Exercise / conversion
M
|
Common Stock | 1,545 | $271.48 | $419,442 | 5,964 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 562 | $0.00 | $0 | 5,624 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 563 | $0.00 | $0 | 5,623 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 304 | $0.00 | $0 | 1,829 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 305 | $0.00 | $0 | 1,828 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 459 | $0.00 | $0 | 917 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 459 | $557.29 | $255,796 | 1,487 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 459 | $171.33 | $78,642 | 1,946 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 305 | $557.29 | $169,973 | 1,487 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 305 | $178.39 | $54,408 | 1,792 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 304 | $557.29 | $169,416 | 1,487 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 304 | $231.00 | $70,223 | 1,791 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 563 | $557.58 | $313,918 | 1,487 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 563 | $238.91 | $134,508 | 2,050 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Open-market sell
S
|
Common Stock | 562 | $557.48 | $313,304 | 1,487 |
| 2018-09-04 | Brogna Salvatore | EVP & Chief Operating Officer |
Exercise / conversion
M
|
Common Stock | 562 | $328.46 | $184,593 | 2,049 |
| 2018-08-31 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 350 | $0.00 | $0 | 25 |
| 2018-08-31 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 350 | $560.00 | $196,000 | 3,966 |
| 2018-08-31 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 350 | $161.27 | $56,443 | 4,316 |
| 2018-08-30 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 19,857 | $0.00 | $0 | 267,008 |
| 2018-08-30 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 10,620 | $0.00 | $0 | 286,865 |
| 2018-08-27 | RUBASH MARK J | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 150 | $0.00 | $0 | 39 |
| 2018-08-27 | RUBASH MARK J | Dir |
Open-market sell
S
|
Common Stock | 150 | $543.66 | $81,549 | 3,966 |
| 2018-08-27 | RUBASH MARK J | Dir |
Exercise / conversion
M
|
Common Stock | 150 | $123.77 | $18,566 | 4,116 |
| 2018-08-22 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 20,000 | $0.00 | $0 | 368,555 |
| 2018-08-22 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 10,000 | $0.00 | $0 | 388,555 |
| 2018-08-15 | Myriam Curet | EVP & Chief Medical Officer |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 6,000 | $0.00 | $0 | 6,000 |
| 2018-08-07 | Rosa David J. | EVP & Chief Commercial Officer |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 1,125 | $0.00 | $0 | 0 |
| 2018-08-07 | Rosa David J. | EVP & Chief Commercial Officer |
Other disposed transaction
F
|
Common Stock | 558 | $0.00 | $0 | 11,708 |
| 2018-08-07 | Rosa David J. | EVP & Chief Commercial Officer |
Exercise / conversion
M
|
Common Stock | 1,125 | $0.00 | $0 | 12,266 |
| 2018-08-06 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 245 | $521.18 | $127,690 | 317,789 |
| 2018-08-01 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 6,861 | $0.00 | $0 | 297,730 |
| 2018-08-01 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 13,443 | $0.00 | $0 | 304,591 |
| 2018-07-31 | KANIA DON R | Dir |
Equity grant / award
A · derivative
|
Restricted Stock Units | 215 | $0.00 | $0 | 215 |
| 2018-07-31 | KANIA DON R | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 647 | $0.00 | $0 | 647 |
| 2018-07-30 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 8,250 | $0.00 | $0 | 0 |
| 2018-07-30 | MOHR MARSHALL | Executive VP & CFO |
Open-market sell
S
|
Common Stock | 8,250 | $508.50 | $4,195,090 | 9,821 |
| 2018-07-30 | MOHR MARSHALL | Executive VP & CFO |
Exercise / conversion
M
|
Common Stock | 8,250 | $111.43 | $919,325 | 18,071 |
| 2018-07-24 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 6,000 | $523.37 | $3,140,227 | 318,034 |
| 2018-07-24 | SMITH LONNIE M | Dir |
Open-market sell
S
|
Common Stock | 50,000 | $523.37 | $26,168,560 | 378,251 |
| 2018-07-24 | BARRATT CRAIG H | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 0 |
| 2018-07-24 | BARRATT CRAIG H | Dir |
Open-market sell
S
|
Common Stock | 2,500 | $522.00 | $1,305,000 | 0 |
| 2018-07-24 | BARRATT CRAIG H | Dir |
Exercise / conversion
M
|
Common Stock | 2,500 | $193.08 | $482,700 | 2,500 |
| 2018-07-23 | Friedman Michael A | Dir |
Exercise / conversion
M · derivative
|
Restricted Stock Units | 975 | $0.00 | $0 | 0 |
| 2018-07-23 | Friedman Michael A | Dir |
Exercise / conversion
M
|
Common Stock | 975 | $0.00 | $0 | 4,419 |
| 2018-05-29 | SMITH LONNIE M | Dir |
Equity grant / award
G
|
Common Stock | 30,000 | $0.00 | $0 | 325,034 |